
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Presymptomatic microRNA-based biomarker signatures for the prognosis of localized radiation injury in mice - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="FF20820E89B737231A820E004632AA03.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333984/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Presymptomatic microRNA-based biomarker signatures for the prognosis of localized radiation injury in mice">
<meta name="citation_author" content="Lucie Ancel">
<meta name="citation_author_institution" content="Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France">
<meta name="citation_author" content="Jules Gueguen">
<meta name="citation_author_institution" content="Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France">
<meta name="citation_author" content="Guillaume Thoër">
<meta name="citation_author_institution" content="Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France">
<meta name="citation_author" content="Jules Marçais">
<meta name="citation_author_institution" content="Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France">
<meta name="citation_author" content="Aïda Chemloul">
<meta name="citation_author_institution" content="Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France">
<meta name="citation_author" content="Bernard Le Guen">
<meta name="citation_author_institution" content="EDF, DPN, 1 place Pleyel, Saint Denis, France">
<meta name="citation_author" content="Marc Benderitter">
<meta name="citation_author_institution" content="ASNR, PSE-SANTE, Fontenay-aux-Roses, France">
<meta name="citation_author" content="Radia Tamarat">
<meta name="citation_author_institution" content="ASNR, PSE-SANTE, Fontenay-aux-Roses, France">
<meta name="citation_author" content="Maâmar Souidi">
<meta name="citation_author_institution" content="Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France">
<meta name="citation_author" content="Mohamed Amine Benadjaoud">
<meta name="citation_author_institution" content="Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France">
<meta name="citation_author" content="Stéphane Flamant">
<meta name="citation_author_institution" content="Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0329737">
<meta name="citation_doi" content="10.1371/journal.pone.0329737">
<meta name="citation_pmid" content="40779592">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333984/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333984/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333984/pdf/pone.0329737.pdf">
<meta name="description" content="The threat of nuclear or radiological events requires early diagnostic tools for radiation induced health effects. Localized radiation injuries (LRI) are severe outcomes of such events, characterized by a latent presymptomatic phase followed by ...">
<meta name="og:title" content="Presymptomatic microRNA-based biomarker signatures for the prognosis of localized radiation injury in mice">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The threat of nuclear or radiological events requires early diagnostic tools for radiation induced health effects. Localized radiation injuries (LRI) are severe outcomes of such events, characterized by a latent presymptomatic phase followed by ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333984/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12333984">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0329737"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0329737.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12333984%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12333984/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12333984/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333984/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0329737" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 8;20(8):e0329737. doi: <a href="https://doi.org/10.1371/journal.pone.0329737" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329737</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Presymptomatic microRNA-based biomarker signatures for the prognosis of localized radiation injury in mice</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ancel%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Lucie Ancel</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Lucie Ancel</span></h3>
<div class="p">
<sup>1</sup>Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France</div>
<div>Data curation, Formal analysis, Investigation, Methodology, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ancel%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lucie Ancel</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gueguen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jules Gueguen</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Jules Gueguen</span></h3>
<div class="p">
<sup>1</sup>Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France</div>
<div>Formal analysis</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gueguen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jules Gueguen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tho%C3%ABr%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Guillaume Thoër</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Guillaume Thoër</span></h3>
<div class="p">
<sup>1</sup>Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France</div>
<div>Data curation, Formal analysis, Methodology</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tho%C3%ABr%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Guillaume Thoër</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mar%C3%A7ais%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Jules Marçais</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Jules Marçais</span></h3>
<div class="p">
<sup>1</sup>Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France</div>
<div>Formal analysis, Software</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mar%C3%A7ais%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jules Marçais</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chemloul%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Aïda Chemloul</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Aïda Chemloul</span></h3>
<div class="p">
<sup>1</sup>Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France</div>
<div>Formal analysis, Methodology</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chemloul%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aïda Chemloul</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Le%20Guen%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Bernard Le Guen</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Bernard Le Guen</span></h3>
<div class="p">
<sup>2</sup>EDF, DPN, 1 place Pleyel, Saint Denis, France</div>
<div>Funding acquisition</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Le%20Guen%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bernard Le Guen</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Benderitter%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Marc Benderitter</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Marc Benderitter</span></h3>
<div class="p">
<sup>3</sup>ASNR, PSE-SANTE, Fontenay-aux-Roses, France</div>
<div>Funding acquisition, Validation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Benderitter%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marc Benderitter</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tamarat%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Radia Tamarat</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Radia Tamarat</span></h3>
<div class="p">
<sup>3</sup>ASNR, PSE-SANTE, Fontenay-aux-Roses, France</div>
<div>Conceptualization, Validation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tamarat%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Radia Tamarat</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Souidi%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Maâmar Souidi</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Maâmar Souidi</span></h3>
<div class="p">
<sup>1</sup>Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France</div>
<div>Conceptualization, Formal analysis, Funding acquisition, Investigation, Supervision, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Souidi%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maâmar Souidi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Benadjaoud%20MA%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Mohamed Amine Benadjaoud</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Mohamed Amine Benadjaoud</span></h3>
<div class="p">
<sup>1</sup>Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France</div>
<div>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Software, Supervision, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Benadjaoud%20MA%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohamed Amine Benadjaoud</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Flamant%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Stéphane Flamant</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Stéphane Flamant</span></h3>
<div class="p">
<sup>1</sup>Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France</div>
<div>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Flamant%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stéphane Flamant</span></a>
</div>
</div>
<sup>1,</sup><sup>*,</sup><sup>#</sup>
</div>
<div class="cg p">Editor: <span class="name western">Daniel X Zhang</span><sup>4</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), PSE-SANTE/SERAMED/LRAcc, Fontenay-aux-Roses, France</div>
<div id="aff002">
<sup>2</sup>EDF, DPN, 1 place Pleyel, Saint Denis, France</div>
<div id="aff003">
<sup>3</sup>ASNR, PSE-SANTE, Fontenay-aux-Roses, France</div>
<div id="edit1">
<sup>4</sup>Hong Kong Metropolitan University, HONG KONG</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors do not report any conflict of interests regarding the publication of this paper. A patent was registered (#B254544FR) for the use of the miRNA signatures described in this manuscript for early diagnosis of localized radiation injuries (M.S., M.A.B, and S.F.).</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>stephane.flamant@asnr.fr</span></p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Lucie Ancel</span></strong>: <span class="role">Data curation, Formal analysis, Investigation, Methodology, Writing – original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jules Gueguen</span></strong>: <span class="role">Formal analysis</span>
</div>
<div>
<strong class="contrib"><span class="name western">Guillaume Thoër</span></strong>: <span class="role">Data curation, Formal analysis, Methodology</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jules Marçais</span></strong>: <span class="role">Formal analysis, Software</span>
</div>
<div>
<strong class="contrib"><span class="name western">Aïda Chemloul</span></strong>: <span class="role">Formal analysis, Methodology</span>
</div>
<div>
<strong class="contrib"><span class="name western">Bernard Le Guen</span></strong>: <span class="role">Funding acquisition</span>
</div>
<div>
<strong class="contrib"><span class="name western">Marc Benderitter</span></strong>: <span class="role">Funding acquisition, Validation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Radia Tamarat</span></strong>: <span class="role">Conceptualization, Validation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Maâmar Souidi</span></strong>: <span class="role">Conceptualization, Formal analysis, Funding acquisition, Investigation, Supervision, Validation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Mohamed Amine Benadjaoud</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Software, Supervision, Validation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Stéphane Flamant</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Validation, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Daniel X Zhang</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 15; Accepted 2025 Jul 20; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Ancel et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12333984  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40779592/" class="usa-link">40779592</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The threat of nuclear or radiological events requires early diagnostic tools for radiation induced health effects. Localized radiation injuries (LRI) are severe outcomes of such events, characterized by a latent presymptomatic phase followed by symptom onset ranging from erythema and edema to ulceration and tissue necrosis. Early diagnosis is crucial for effective triage and adapted treatment, potentially through minimally invasive biomarkers including circulating microRNAs (miRNAs), which have been correlated with tissue injuries and radiation exposure, suggesting their potential in diagnosing LRI. In this study, we sought to identify early miRNA signatures for LRI severity prognosis before clinical symptoms appear. Using a mouse model of hindlimb irradiation at 0, 20, 40, or 80 Gy previously shown to lead to localized injuries of different severities, we performed broad-spectrum plasma miRNA profiling at two latency stages (day 1 and 7 post-irradiation). The identified candidate miRNAs were then challenged using two independent mouse cohorts to refine miRNA signatures. Through sparse partial least square discriminant analysis (sPLS-DA), signatures of 14 and 16 plasma miRNAs segregated animals according to dose groups at day 1 and day 7, respectively. Interestingly, these signatures shared 9 miRNAs, including miR-19a-3p, miR-93-5p, miR-140-3p, previously associated with inflammation, radiation response and tissue damage. In addition, the Bayesian latent variable modeling confirmed significant correlations between these prognostic miRNA signatures and day 14 clinical and functional outcomes from unrelated mice. This study identified plasma miRNA signatures that might be used throughout the latency phase for the prognosis of LRI severity. These results suggest miRNA profiling could be a powerful tool for early LRI diagnosis, thereby improving patient management and treatment outcomes in radiological emergency situations.</p></section><section id="sec001"><h2 class="pmc_sec_title">Introduction</h2>
<p>The eventuality of a serious nuclear or radiological event is a major concern considering the ever-growing malevolent threats and current geopolitical situation. In such cases, exposure to high doses of ionizing radiations (IR) can lead to severe health consequences on populations. Therefore, the World Health Organization (WHO) recently highlighted the urgent need for medical countermeasure development, including research about new early diagnostic tools for the medical triage of people exposed to IR during mass accident and radiological emergencies [<a href="#pone.0329737.ref001" class="usa-link" aria-describedby="pone.0329737.ref001">1</a>]. Among various radiation-induced biological consequences, one of the most severe and frequent consists in radiological burns, also called localized radiation injuries (LRI) [<a href="#pone.0329737.ref002" class="usa-link" aria-describedby="pone.0329737.ref002">2</a>,<a href="#pone.0329737.ref003" class="usa-link" aria-describedby="pone.0329737.ref003">3</a>].</p>
<p>LRIs are consecutive to localized exposure to high doses of IR, and are characterized, after an initial and transitory erythema, by a latency phase of variable duration with no overt symptoms, followed by the onset of clinical manifestations [<a href="#pone.0329737.ref004" class="usa-link" aria-describedby="pone.0329737.ref004">4</a>–<a href="#pone.0329737.ref007" class="usa-link" aria-describedby="pone.0329737.ref007">7</a>]. After the presymptomatic stage, LRI may present a gradual occurrence of symptoms, with severity and celerity of appearance associated with the radiation dose and the surface of exposed tissue. A second erythema may appear along with edema, followed by the onset of dry to exudative desquamation according to the extent of epidermal destruction, and in most severe cases, by tissue necrosis [<a href="#pone.0329737.ref004" class="usa-link" aria-describedby="pone.0329737.ref004">4</a>–<a href="#pone.0329737.ref007" class="usa-link" aria-describedby="pone.0329737.ref007">7</a>]. While clinical manifestations may regress, depending on the exposure severity and medical care effectiveness, late effects of injury may appear months or years after the exposure, which are characterized by unpredictable inflammatory waves with expansion of a fibro-necrotic tissue [<a href="#pone.0329737.ref008" class="usa-link" aria-describedby="pone.0329737.ref008">8</a>,<a href="#pone.0329737.ref009" class="usa-link" aria-describedby="pone.0329737.ref009">9</a>]. Treatment recommendations of severe LRI involve a complex combination of surgery and cellular therapy, which effectiveness would benefit from early implementation [<a href="#pone.0329737.ref009" class="usa-link" aria-describedby="pone.0329737.ref009">9</a>]. Current diagnosis of LRI is usually performed after the appearance of symptoms, and essentially relies on clinical assessment, magnetic resonance imaging, plasma CRP quantification and when available, physical reconstruction of the absorbed radiation dose [<a href="#pone.0329737.ref002" class="usa-link" aria-describedby="pone.0329737.ref002">2</a>]. Therefore, a new early diagnosis method able to predict the appearance of LRI and its severity before clinical manifestations would be crucial for identification of populations during radiological emergencies. This would improve medical care of patients with enhancement of treatment response and reducing risk of resurgence. Omics approaches allow the identification of relevant molecules (RNA, proteins, metabolites) whose expression levels vary in response to specific stressors. These molecules can be measured in biofluids or tissues and serve as biomarkers of pathophysiological conditions [<a href="#pone.0329737.ref010" class="usa-link" aria-describedby="pone.0329737.ref010">10</a>].</p>
<p>MicroRNAs (miRNAs) are small non-coding RNA molecules involved in the post-transcriptional regulation of gene expression. Circulating miRNAs are promising candidate biomarkers since they are stable, accessible with minimally invasive blood collection, and easily analyzed with widespread, affordable analytical tools [<a href="#pone.0329737.ref011" class="usa-link" aria-describedby="pone.0329737.ref011">11</a>]. The usefulness of miRNAs as biomarkers of human pathologies has been demonstrated in a large number of studies, notably in cancers and cardiovascular diseases [<a href="#pone.0329737.ref012" class="usa-link" aria-describedby="pone.0329737.ref012">12</a>–<a href="#pone.0329737.ref014" class="usa-link" aria-describedby="pone.0329737.ref014">14</a>]. miRNAs are present both in tissues and blood, and interestingly, changes in circulating miRNA expression have already been correlated with specific tissue injuries [<a href="#pone.0329737.ref015" class="usa-link" aria-describedby="pone.0329737.ref015">15</a>]. Notably, Jinnin’s group described miRNAs as key regulators and serum biomarkers of severe skin damage resulting from drug induced cutaneous toxicity [<a href="#pone.0329737.ref016" class="usa-link" aria-describedby="pone.0329737.ref016">16</a>,<a href="#pone.0329737.ref017" class="usa-link" aria-describedby="pone.0329737.ref017">17</a>]. miRNAs have been identified as circulating biomarkers of whole body irradiation exposure in various preclinical models as well as in patients after radiotherapy [<a href="#pone.0329737.ref018" class="usa-link" aria-describedby="pone.0329737.ref018">18</a>–<a href="#pone.0329737.ref021" class="usa-link" aria-describedby="pone.0329737.ref021">21</a>]. In addition, Yadav et al recently described the strong correlation of blood miR-150-5p expression variations with irradiation doses in mice and in patients undergoing myeloablative conditioning irradiation [<a href="#pone.0329737.ref022" class="usa-link" aria-describedby="pone.0329737.ref022">22</a>]. The results of these studies suggest the potential usefulness of miRNA measurements in complement to current tools dedicated to the management of nuclear and radiological events or radiotherapy treatments, by predicting radiation induced toxicity. Differential miRNA expression can also provide predictive information on organ-specific syndromes after irradiation. For example, early expression of some plasma miRNAs predicts the onset of radiation-induced pneumonia and pulmonary fibrosis in mice [<a href="#pone.0329737.ref023" class="usa-link" aria-describedby="pone.0329737.ref023">23</a>] and non-human primates [<a href="#pone.0329737.ref024" class="usa-link" aria-describedby="pone.0329737.ref024">24</a>] after whole-chest irradiation (around 10 Gy). Interestingly, it has been documented that tissue miRNA alterations were associated with acute and late stages of radiation-induced fibrosis in a murine skin model [<a href="#pone.0329737.ref025" class="usa-link" aria-describedby="pone.0329737.ref025">25</a>]. Moreover, we recently demonstrated the interest of using miRNAs as biomarkers of LRI. Using a preclinical model of hindlimb irradiation, we identified a plasma signature of miRNAs able to discriminate mice according to dose group and injury severity at the manifestation phase [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>]. Taken together, this information highlights the potential value of miRNAs as circulating biomarkers for the prognosis of LRI appearance and severity.</p>
<p>Building on our previous study [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>], here we aimed to identify early circulating miRNA signature able to predict the appearance and severity of LRI before the onset of clinical manifestations. To this end, we used a similar preclinical model of localized irradiation to perform an integrative approach including clinical, functional and molecular data through adequate biomathematical methods. We conducted broad-spectrum miRNA profiling studies at two different endpoints during latency phase, namely day 1 (early stage) and day 7 (late stage) after irradiation. MiRNA prognostic signatures were further refined using independent animal cohorts for each timepoint.</p></section><section id="sec002"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="sec003"><h3 class="pmc_sec_title">Experimental model</h3>
<section id="sec004"><h4 class="pmc_sec_title">Animals.</h4>
<p>The experiments were conducted in accordance with French veterinary guidelines and those established by the European Community for the use of experimental animals. The protocols were approved by the institutional animal experimentation and ethics committee (APAFIS Agreement No. 22393-2019101116207862v1) and were conducted following the ARRIVE guidelines (<a href="http://arriveguidelines.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://arriveguidelines.org</a>). A total of 240 male 8-week-old C57BL/6 mice (Janvier Labs, Le Genest Sainte Isle, France) were used in this study. We applied humane endpoint criteria involving euthanasia of animals when they showed signs of pain, sickness, suffering, or moribund conditions. In particular: loss of body weight, reduced mobility, and hunched body posture were used as main criteria to recognize humane endpoint. No mice died before meeting criteria of euthanasia, nor did they reach endpoint criteria during the course of the study. All animals were euthanized at the end of experiment (<em>i.e.</em>, 24h or 7 days post-irradiation) by cervical dislocation following intracardiac blood sampling. The animals were housed in cages (4 mice per cage) within a temperature and humidity-controlled chamber, with alternating 12-hour light and dark cycles and ad libitum access to water and food. Mice were acclimated for one week upon arrival before undergoing experimental procedures. Animal health and behavior were checked daily from arrival to end of experiment.</p></section><section id="sec005"><h4 class="pmc_sec_title">Study design.</h4>
<p>Four animal cohorts of 60 mice each were used during this study, with two cohorts for day (D) 1 endpoint analysis and two cohorts for D7 analysis (<a href="#pone.0329737.g001" class="usa-link">Fig 1A</a>). For each time point (end of experiment), the study was conducted in two phases using two separate animal cohorts. Initially, 60 mice (15 per group) were used for broad-spectrum screening to identify a preliminary miRNA signature capable of distinguishing individuals according to dose group. This preliminary signature was then challenged using an independent cohort of 60 mice (15 per group), by measuring plasma levels of selected miRNAs in order to establish the final miRNA signatures.</p>
<figure class="fig xbox font-sm" id="pone.0329737.g001"><h5 class="obj_head">Fig 1. Pathophysiology of the localized radiation injury at early timepoints.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333984_pone.0329737.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/12333984/f78d38480c1e/pone.0329737.g001.jpg" loading="lazy" height="1299" width="620" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329737.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Experimental design. Two independent mice cohorts were used to perform a broad-spectrum profiling of miRNAs (cohort 1) and then a targeted study (cohort 2) for each time points (D1 and D7, end of experiment). For each cohort, mice were irradiated on their left hindlimb according to 4 irradiation groups with 20, 40 or 80 Gy and 0 for the control group (N = 15/group) with 10 MV X-rays (D0). Clinical and functional analyses were performed at D1 and D7, respectively. Mice were euthanized at D1 or D7 after blood samplings. Data of injury score measured at D14 that are presented in this figure for comparison with those obtained at D1 and D7 were retrieved from our previous studies [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>,<a href="#pone.0329737.ref027" class="usa-link" aria-describedby="pone.0329737.ref027">27</a>]. (B) Mean injury scores assessed for each group at D1 (n = 15/group), D7 (n = 15/group) and D14 (n = 9–15/group) after local irradiation. Each animal is represented. Kruskal-Wallis analysis, * P &lt; 0.05; *** P &lt; 0.001; **** P &lt; 0.0001. (C) Representative photographs of irradiated limbs at D1, D7 and D14 post-irradiation for all dose groups (each photograph corresponds to a distinct animal).</p></figcaption></figure></section><section id="sec006"><h4 class="pmc_sec_title">Irradiation &amp; experimental procedure.</h4>
<p>Mice hair was removed from both hindlimbs with clippers and depilatory cream. Then, the left hindlimb (foot excepted) was irradiated with X-rays using a medical linear accelerator (Elekta SAS, Boulogne-Billancourt, France) with a tension of 10 MV and a dose rate of 3.25 Gy/min under isoflurane anesthesia. Dose rate measurements were taken with an ionization chamber (PTW 31,010–0125 cc) in Kair on a plexiglass plate, with an uncertainty of 5% at k = 2. Mice were randomly assigned to four dose groups and irradiated 5 at a time with single doses of 20, 40, or 80 Gy, while the control group received 0 Gy (N = 15/group). The irradiation field was a rectangle of 2 × 30 cm, and the source-to-sample distance was 1 m. All handling and non-invasive procedures were performed under isoflurane anesthesia, except for weighing, which was carried out before irradiation and prior to euthanasia. One or seven days after irradiation, mice were euthanized by cervical dislocation following intracardiac blood sampling. For each analytical timepoint, this entire procedure was repeated on a second independent cohort (N = 15 animals/group) to refine the miRNA signatures, under the same conditions. Any animal showing signs of skin injury resulting from aggressive behavior within the cages was excluded from all analyses.</p></section></section><section id="sec007"><h3 class="pmc_sec_title">Sample collection</h3>
<p>At the end of experiment (D1 or D7 after exposure), collection of 100 μL retro-orbital blood was performed using micropipettes, followed by transfer to BD Microtainer K2 EDTA tubes (BD Biosciences, Le Pont de Claix, France) for analysis of complete blood count (CBC).</p>
<p>A syringe pre-coated with 0.105 M sodium citrate was used to collect around 1 mL of intracardiac blood which was transferred to a 1.5 mL tube containing 75 μL of 0.105 M sodium citrate. The blood samples were processed to obtain platelet-poor plasma (PPP) with two consecutive centrifugations at 1,500 x <em>g</em>, 15 min, 4°C and 13,000 x <em>g</em>, 2 min, 4°C. PPPs were stored at −80°C until use.</p></section><section id="sec008"><h3 class="pmc_sec_title">Clinical approach</h3>
<section id="sec009"><h4 class="pmc_sec_title">Injury score.</h4>
<p>When signs of radiation injury were present (only at D7), an observational injury score was established by two independent experimenters according to a blind analysis, as previously described [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>]. For observational score at D14 (see <a href="#pone.0329737.g001" class="usa-link">Fig 1</a>), data were retrieved from our previous studies [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>,<a href="#pone.0329737.ref027" class="usa-link" aria-describedby="pone.0329737.ref027">27</a>].</p></section><section id="sec010"><h4 class="pmc_sec_title">Cutaneous blood perfusion.</h4>
<p>Assessment of limb cutaneous blood perfusion was performed using a Moor LDI2 Laser Doppler Imager (Moor Instruments ltd, Axminster, UK). The measurements lasted for 4 minutes with mice under anesthesia with isoflurane on a heating plate set to 37°C to avoid temperature variation. Analysis of blood perfusion was performed by computing the blood flow ratio between the irradiated limb (IRR) and the non-irradiated, contralateral one (NIR).</p></section><section id="sec011"><h4 class="pmc_sec_title">Trans-epidermal water loss.</h4>
<p>Trans-epidermal water loss (TEWL) was assessed using a Tewameter® (Courage + Khazaka Electronic GmbH, Köln, Germany). A sensor was placed on the surface of the NIR and IRR limbs for approximately 30 seconds each, which recorded a measurement of water loss (g/h/m<sup>2</sup>) every second. TEWL data were expressed as the difference of TEWL mean value between IRR and NIR limbs for each animal.</p></section><section id="sec012"><h4 class="pmc_sec_title">C-reactive protein (CRP) levels and complete blood count (CBC).</h4>
<p>To replicate standard clinical management, we assessed markers of inflammation (CRP levels) and overall health (CBC) at D1 and D7 post-irradiation. CRP quantification was conducted using the Mouse C-Reactive Protein Quantikine ELISA test (R&amp;D Systems, Abingdon, UK) following the manufacturer’s protocol, with plasma diluted at 1:4000 using the provided buffer. CBC analysis was carried out on EDTA whole blood using a VetScan HM5 hematology analyzer (Abaxis Europe GmbH, Griesheim, Germany) according to the manufacturer’s instructions.</p></section></section><section id="sec013"><h3 class="pmc_sec_title">Molecular approach</h3>
<section id="sec014"><h4 class="pmc_sec_title">MiRNA extraction and quality control.</h4>
<p>Total RNAs were isolated from PPP samples using the miRNeasy® Plasma/Serum Advanced kit (Qiagen, Courtaboeuf, France) following the manufacturer’s instructions. A quality control was performed as previously described [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>], using qPCR analysis of three distinct miRNA assays as controls, including a universally expressed miRNA (miR-23a-3p), a miRNA indicative of potential hemolysis (miR-451a), and an exogenous miRNA (cel-miR-39 RNA spike-in control, Qiagen) that was introduced into the sample prior to extraction to monitor the extraction efficiency. The extent of hemolysis in each sample was evaluated by calculating the difference between the expression levels of miR-23a-3p and miR-451a, following a previously established method [<a href="#pone.0329737.ref028" class="usa-link" aria-describedby="pone.0329737.ref028">28</a>]. Samples that did not meet the quality criteria were excluded from the study.</p></section><section id="sec015"><h4 class="pmc_sec_title">Broad-spectrum and targeted qPCR analysis.</h4>
<p>Following manufacturer’s procedure, reverse transcription was performed with the miRCURY® LNA RT Kit (Qiagen), using a Mastercycler® X50 (Eppendorf). For the broad-spectrum profiling, qPCR was performed using the miRCURY® LNA miRNA miRNome PCR Panels Kit, on Mouse &amp; Rat panel I + II (Qiagen) and the miRCURY® LNA SYBR Green PCR Kit (Qiagen). MiRCURY® LNA miRNA custom PCR panels were used for the targeted analysis. The amplification was run on a Quant Studio 12-PLEX instrument (Applied Biosystems, Foster City, CA) in 10 µL reaction volume for 40 cycles, using 3 μL of cDNA (1:30 dilution), completed with melting curve analysis. Cycle thresholds (Ct) for each assay were determined using automatic baseline with Expression-Suite Software v1.3 (Applied Biosystems), and Ct values&gt;37 were discarded. Delta-Ct values were calculated using adaptive normalization from “MiRAnorm” package in R Software, as described [<a href="#pone.0329737.ref029" class="usa-link" aria-describedby="pone.0329737.ref029">29</a>]. Briefly, delta-Ct values were obtained by subtracting the assay’s Ct values by the mean of an adaptive set of normalizing miRNAs derived from the data through a hierarchical clustering approach based on Euclidean distance and Ward agglomeration method. This set of normalizing miRNAs was obtained by cutting the dendrogram tree from bottom up according to a pre-specified number of three normalizing miRNAs and the most stable cluster minimizing the sum of all distances from its centroid was retained. Normalized (-)delta-Ct values were used for multivariate analysis and generation of miRNA signatures from broad-spectrum and targeted studies.</p></section></section><section id="sec016"><h3 class="pmc_sec_title">Statistical and multivariate analysis</h3>
<p>Using GraphPad Prism® v9, a Kruskal-Wallis test (non-parametric) was employed to conduct statistical analyses regarding variations in weight, CBC, CRP levels, injury scores, TEWL and cutaneous blood perfusion.</p>
<p>In order to model multi-scale signatures (miRNAs and clinical data) able to simultaneously identify dose groups and highlight the most significant correlations between different entities of each scale, a supervised multivariate analysis was performed on datasets collected at each time point separately. Two blocks of covariates were defined for each sample: (1) miRNA block with miRNA plasma expression, and (2) Clinical block with CRP, CBC, weight, injury score, TEWL and cutaneous blood perfusion, when available [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>].</p>
<p>More precisely, a sparse Multiblock partial least square discriminant analysis (sPLS-DA) model [<a href="#pone.0329737.ref030" class="usa-link" aria-describedby="pone.0329737.ref030">30</a>] was conducted via the DIABLO framework of the package ‘mixOmics’ (version 6.18.1) in R software. DIABLO constructed miRNA and clinical block components optimizing their correlation with respect to the dose treatment groups. These components were defined as a linear combination of the original covariates and a Lasso penalization was applied to the loss function of the model to ensure sparsity, variable selection, and interpretability. In all the analyses, leave-one-out cross validation was used to determine the model parameters including number of components and number of features per component.</p>
<p>sPLS-DA DIABLO signature described above was by construction based on correlation with the dose groups and the D1 and D7 clinical data. However, its prognostic ability can be assessed through its capacity to predict a future (post D7) LRI injury. We propose in this study to use clinical D14 data collected in our previous work [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>] as a prediction end-point to challenge our prognostic D1-D7 miRNA signatures.</p>
<p>The investigation of the statistical association between the D1 and D7 sPLS-DA coordinates on one hand, and the clinical and functional parameters at D14 on the other hand, is challenging since these two measures were performed on different animal cohorts. This makes the classical statistical approaches inefficient since predictive and response variables are not observed on the same subject. The Bayesian latent variable model [<a href="#pone.0329737.ref031" class="usa-link" aria-describedby="pone.0329737.ref031">31</a>] offers the possibility to include priors on the distribution of the D1 and D7 sPLS-DA coordinates in the different dose groups to estimate their correlation with the clinical and functional parameters at D14. The model fitting was performed using JAGS software via Markov chain Monte Carlo [<a href="#pone.0329737.ref032" class="usa-link" aria-describedby="pone.0329737.ref032">32</a>].</p></section></section><section id="sec017"><h2 class="pmc_sec_title">Results</h2>
<section id="sec018"><h3 class="pmc_sec_title">Pathophysiology of LRI at early timepoints</h3>
<p>In our LRI mouse model, mice showed no manifestation of injury at D1 post-irradiation, as shown in <a href="#pone.0329737.g001" class="usa-link">Fig 1B</a> and <a href="#pone.0329737.g001" class="usa-link">1C</a>, irrespective of radiation dose. Seven days after irradiation, the majority of mice did not show any sign of injury, except for 4 and 2 mice exposed at 80 and 40 Gy, respectively, which manifested slight erythema and, sometimes, sagging skin appearance, with no significant difference between irradiated and control groups (<a href="#pone.0329737.g001" class="usa-link">Fig 1B</a> and <a href="#pone.0329737.g001" class="usa-link">1C</a>). However, at D14 post-irradiation, irradiated mice displayed injuries with severity associated with the dose, as previously shown in our proof-of-concept study [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>] (<em>P</em> &lt; 0.05).</p>
<p>Cutaneous blood perfusion of irradiated limbs showed no difference between dose groups, or between irradiated groups and controls at D1 post-irradiation (<a href="#pone.0329737.g002" class="usa-link">Fig 2A</a>). Similarly, TEWL measurement on both irradiated and non-irradiated limbs did not reveal any difference between groups, indicating no alteration of skin barrier function at that timepoint (<a href="#pone.0329737.g002" class="usa-link">Fig 2A</a>). The inability to detect injury with absence of clinical signs and functional impairment agrees with the characteristic presymptomatic, latency phase observed at D1 after irradiation in our preclinical model (<a href="#pone.0329737.g001" class="usa-link">Fig 1B</a> and <a href="#pone.0329737.g001" class="usa-link">1C</a>). While plasma CRP level was similar in all groups (<a href="#pone.0329737.g002" class="usa-link">Fig.2A</a>), CBC analysis showed a gradual decrease in lymphocyte counts with increasing dose, which was significant for the 80 Gy group (<em>P</em> &lt; 0.001 vs control; <em>P</em> &lt; 0.05 vs 20 Gy and 40 Gy, <a href="#pone.0329737.g002" class="usa-link">Fig 2A</a>), whereas the remaining features of CBC showed no difference between groups (<a href="#pone.0329737.s001" class="usa-link">S1 Fig</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329737.g002"><h4 class="obj_head">Fig 2. Clinical and biological monitoring.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333984_pone.0329737.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/12333984/f0689efb9443/pone.0329737.g002.jpg" loading="lazy" height="512" width="700" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329737.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Blood-flow ratio of irradiated limb and non-irradiated limb (IRR/NIR) for each group, difference between transepidermal water loss (TEWL) measured on irradiated limb over non-irradiated one (IRR-NIR) for each group (g/h/m²), plasma CRP level (ng/mL) and lymphocyte (LYM) count (10<sup>9</sup>/L) at (A) D1 post-irradiation (n = 13–15/group) and (B) D7 post-irradiation (n = 12–15/group). Each animal is represented. Kruskal-Wallis analysis, * P &lt; 0.05; ** P &lt; 0.01; *** P &lt; 0.001; **** P &lt; 0.0001.</p></figcaption></figure><p>At D7 post-irradiation, mice from the 80 Gy group displayed significantly increased blood flow on their irradiated limb when compared to non-irradiated group (<em>P</em> &lt; 0.01) (<a href="#pone.0329737.g002" class="usa-link">Fig 2B</a>). On the other hand, there was no significant modification of TEWL from irradiated limbs for any group (<a href="#pone.0329737.g002" class="usa-link">Fig 2B</a>). Similarly, no difference was observed for plasma CRP level and CBC between groups at that timepoint (<a href="#pone.0329737.g002" class="usa-link">Fig 2B</a> and <a href="#pone.0329737.s002" class="usa-link">S2 Fig</a>). Hence at D7 post-irradiation, most animals remain in the latency phase of the injury, with a few mice irradiated at 80 Gy starting to show mild erythema and increasing blood perfusion on their irradiated limbs. Apart from skin perfusion analysis, these results are similar to those obtained in our previous study using the same preclinical model of radiological burn with mice monitored on day 7, 10 and 14 post-irradiation [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>].</p></section><section id="sec019"><h3 class="pmc_sec_title">Broad-spectrum profiling of plasma miRNAs during early and late stage of latency</h3>
<p>A broad-spectrum profiling of plasma miRNAs was performed on 750 miRNAs on plasma samples collected at D1 post-irradiation. Expression data of ~300 reproducibly detected miRNAs, along with information from clinical, functional, and biological monitoring were simultaneously analyzed through multivariate analysis (sPLS-DA) in order to classify mice according to their dose group and identify correlations between 2 blocks of variables. The “Macro” block, composed of data from skin perfusion, water loss, CRP, and CBC levels, failed to segregate dose groups (<a href="#pone.0329737.g003" class="usa-link">Fig 3A</a>). On the other hand, the “miR” block, composed of miRNA expression levels, allowed the groups segregation at D1 after the exposure. The model identified a panel of 7 stably selected miRNAs (stability scores ≥0.5), which segregated well the control group, the 40 Gy and the 80 Gy groups from each other’s, and to a lesser extent the 20 Gy group (<a href="#pone.0329737.g003" class="usa-link">Fig 3A</a>). The multivariate analysis was optimized to maximize inter-block correlations, resulting in particular, in correlations between miR-208a-3p levels and WBC (lymphocytes) and between miR-191-5p and CRP levels (<a href="#pone.0329737.g003" class="usa-link">Fig 3B</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329737.g003"><h4 class="obj_head">Fig 3. Broad-spectrum profiling of plasma miRNA at early (D1) and late stage of latency (D7).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333984_pone.0329737.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/12333984/2b82b8e76cc1/pone.0329737.g003.jpg" loading="lazy" height="689" width="703" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329737.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Multi-block sPLS-DA scatter plots, with miR block = plasma miRNA expression levels; macro block = cutaneous perfusion, TEWL, CRP, and CBC levels at D1 post-irradiation. (B) Multi-scale correlations between miRNA expression levels and clinical, functional, and biological analyses are illustrated in a circle plot, with positive correlations represented in orange and negative correlations in black, with a cut-off of 0.5. Expression of each parameter as a function of irradiation group is represented with external lines. Control group: n = 10; 20 Gy: n = 9; 40 Gy: n = 10; 80 Gy: n = 10. (C) Multi-block sPLS-DA scatter plots, with miR block = plasma miRNA expression levels; macro block = injury score, cutaneous perfusion, TEWL, CRP, and CBC levels at D7 post-irradiation. (D) Multi-scale correlations between miRNA expression levels and clinical, functional, and biological analyses are illustrated in a circle plot with a cut-off of 0.5. Control group: n = 10; 20 Gy: n = 9; 40 Gy: n = 9; 80 Gy: n = 10.</p></figcaption></figure><p>A similar multi-block analysis was performed on an independent cohort at D7 post-irradiation, corresponding to the end of the latency phase, with the “miR” block comprising D7 expression levels of 270 plasma miRNAs and the “Macro” block, composed of D7 functional and biological data including skin perfusion, TEWL, CBC, CRP, and injury score. The multivariate analysis resulted in the identification of a panel of 32 miRNAs allowing group separation, although less efficiently compared to D1 model (<a href="#pone.0329737.g003" class="usa-link">Fig 3C</a>). Multi-scale correlations highlighted by the sPLS multi-block analysis were found between different plasma miRNAs and CBC parameters such as lymphocyte counts or clinical features such as skin perfusion (<a href="#pone.0329737.g003" class="usa-link">Fig 3D</a>).</p></section><section id="sec020"><h3 class="pmc_sec_title">Targeted analysis of plasma miRNAs during early and late stage of latency</h3>
<p>Based on the results obtained above from broad-spectrum analyses in D1 and D7 animal cohorts and from the previously published D14 animal cohorts, a selected miRNA panel was designed including the most relevant miRNAs identified with highest stability scores and discriminatory power by multivariate analyses. This panel was used to perform targeted miRNA expression analysis from D1 and D7 plasmas of 2 independent cohorts of animals, locally exposed to the same IR doses and monitored for the same biological and functional parameters as above (see Methods).</p>
<p>The DIABLO analysis performed on D1 plasma miRNA expression levels led to the identification of a 14-miRNA signature allowing best achievable segregation of dose groups (<a href="#pone.0329737.g004" class="usa-link">Fig 4A</a>). The signature is made up of two dimensions (two sets of miRNAs) which are associated with various aspects of the pathophysiological model. Thus, the DIABLO dimension 1 is the signature component related to the irradiation dose with a mean score significantly different for the 80 Gy group compared to the control group (<a href="#pone.0329737.g004" class="usa-link">Fig 4B</a>, <em>P</em> &lt; 0.05). On the other hand, the second component contributed to distinguish, though not significantly, the 20 Gy from the 40 Gy groups (DIABLO dimension 2, <a href="#pone.0329737.g004" class="usa-link">Fig 4B</a>). Consistent with these results, most miRNAs from the identified signature mainly contributed to the 80 Gy group separation (<a href="#pone.0329737.g004" class="usa-link">Fig 4C</a>), while miR-208-3p mainly contributed to the distinction of the control group and miR-324-3p and miR-92a-3p to the 20 Gy group. ROC curves analysis showed the ability of this D1 miRNA signature in segregating each group from the others, with area under the curve (AUC) values ranging from 0.74 to 0.80 with significant <em>p</em>-values (<em>P</em> &lt; 0.05, <a href="#pone.0329737.g004" class="usa-link">Fig 4D</a>). The DIABLO model also determined multiscale correlations between the two blocks and between variables inside each block (<a href="#pone.0329737.g004" class="usa-link">Fig 4E</a>). Especially, data from CBC including lymphocyte count were related to several miRNAs. Most miRNAs of the signature were negatively correlated with lymphocyte count, except for miR-208a-3p which displayed a positive correlation with this parameter. Hematocrit, hemoglobin and red blood cell count were also positively correlated with miR-208a-3p, miR-92a-3p and miR-16-5p.</p>
<figure class="fig xbox font-sm" id="pone.0329737.g004"><h4 class="obj_head">Fig 4. Targeted analysis of plasma miRNAs at early stage of latency (D1).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333984_pone.0329737.g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/12333984/71096ac24638/pone.0329737.g004.jpg" loading="lazy" height="1040" width="716" alt="Fig 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329737.g004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Multi-block sPLS-DA scatter plots, with miR block = plasma expression level of 14 miRNAs. (B) Boxplots of scores in each component (DIABLO dimension 1 and DIABLO dimension 2) of the signature according to the dose groups. (C) MiRNAs included in sPLS analysis are plotted with their loading values, representing the main contribution (coefficients in a linear combination) of the selected original miRNAs. Colours indicate the dose group in which the median expression of each miRNA is maximum. (D) ROC curves demonstrating good performances of the signature for dose group segregation, characterized by AUCs (outcome) &gt; 0.738. (E) Multi-scale correlations between miRNA expression levels and clinical, functional, and biological data are illustrated in a heat-map, with positive correlations represented in red and negative correlations in blue (the stronger the darker). Control group: n = 7; 20 Gy: n = 10; 40 Gy: n = 10; 80 Gy: n = 9.</p></figcaption></figure><p>Similarly, the DIABLO multi-block analysis on D7 samples led to the identification of a 16-miRNA panel able to distinguish experimental groups from each other (<a href="#pone.0329737.g005" class="usa-link">Fig 5A</a>). The first component of the signature displayed a higher score for the 80 Gy group (<a href="#pone.0329737.g005" class="usa-link">Fig 5B</a>), with a significant difference compared to the 40 Gy group (<em>P</em> &lt; 0.0001) which indicates the capacity of this component to distinguish between animals exposed to these 2 high doses. On the other hand, the second component showed a mean score statistically lower for the 20 Gy group compared to the control group and the 40 Gy group. Loading plot analysis showed that most miRNAs of the first component displayed a main contribution to the segregation of the 80 and 40 Gy groups (<a href="#pone.0329737.g005" class="usa-link">Fig 5C</a>), while miRNAs from the second component accounted evenly for the distinction of all dose groups (<a href="#pone.0329737.g005" class="usa-link">Fig 5D</a>). The D7 signature showed great performances for the distinction of groups, especially for the 40 and 80 Gy groups, with AUC values of 0.88 (<em>P</em> &lt; 0.001) and 0.93 (<em>P</em> &lt; 0.001), respectively (<a href="#pone.0329737.g005" class="usa-link">Fig 5E</a>). Notably, the model could also distinguish the control and 20 Gy groups with good performances (AUC &gt; 0.75, <em>P</em> &lt; 0.05). Similarly to D1 analysis, the multivariate analysis identified multi-scale correlations between specific miRNAs (e.g. miR-92a-3p, miR-93-5p, miR-19a-3p, miR-186-5p, miR-16-5p, miR-140-3p), skin perfusion and CBC features including WBC, lymphocyte, and neutrophil counts (<a href="#pone.0329737.g005" class="usa-link">Fig 5F</a>).</p>
<figure class="fig xbox font-sm" id="pone.0329737.g005"><h4 class="obj_head">Fig 5. Targeted analysis of plasma miRNA at late stage of latency (D7).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333984_pone.0329737.g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a533/12333984/fe65691979d1/pone.0329737.g005.jpg" loading="lazy" height="1306" width="774" alt="Fig 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0329737.g005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Multi-block sPLS-DA scatter plots, with miR block = plasma expression level of 16 miRNAs. (B) boxplots of scores in each component (DIABLO dimension 1 and DIABLO dimension 2) of the signature according to dose groups. (C-D) MiRNAs included in sPLS analysis are plotted with their loading values for component 1 (C) and component 2 (D). (E) ROC curves demonstrating the performances of the signature for dose group segregation. (F) Multi-scale correlations between miRNA expression levels and clinical, functional, and biological data are illustrated in a heat-map, with positive correlations represented in red and negative correlations in blue (the stronger the darker). Control group: n = 7; 20 Gy: n = 9; 40 Gy: n = 9; 80 Gy: n = 9.</p></figcaption></figure></section><section id="sec021"><h3 class="pmc_sec_title">Early “latency” signatures of localized radiation injury and correlations with expected injury severity</h3>
<p>Final components of D1 and D7 signatures are listed in <a href="#pone.0329737.t001" class="usa-link">Table 1</a>, together with their stability scores. Interestingly, the two signatures share 9 miRNAs in common (<a href="#pone.0329737.t002" class="usa-link">Table 2</a>, with their putative functions according to the literature), with miR-139-5p already being part of our previously identified diagnostic miRNA signature associated with LRI severity at D14 [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>]. To go further toward the potential prognostic application of these “latency” signatures, and building on previous demonstration that irradiation dose is strongly correlated with LRI severity in our mouse model [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>], we used the Bayesian latent variable model [<a href="#pone.0329737.ref031" class="usa-link" aria-describedby="pone.0329737.ref031">31</a>] to infer correlations between the present D1 and D7 miRNA signatures and the clinical and functional parameters recorded during manifestation phase at D14 post-irradiation in independent animal cohorts from our previous study (see Materials &amp; Methods) [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>]. Results from this modeling revealed interesting significant associations between D1 signature and injury score at D14 post-irradiation (<em>r</em> = 0.76, <em>P &lt; </em>0.001), as well as with skin perfusion at D14 (<em>r</em> = 0.87, <em>P &lt; </em>0.01, <a href="#pone.0329737.t001" class="usa-link">Table 1</a>). Furthermore, the miRNA signature identified at D7 post-irradiation significantly correlated with injury score and skin perfusion at D14 post-irradiation (<em>p</em>-values&lt;0.05).</p>
<section class="tw xbox font-sm" id="pone.0329737.t001"><h4 class="obj_head">Table 1. Early signatures of localized radiation injury and correlations between early « latency » signatures and expected injury severity.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead>
<tr>
<th align="left" colspan="5" rowspan="1">D1 miRNA Signature</th>
<th align="left" colspan="5" rowspan="1">D7 miRNA Signature</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Component</th>
<th align="left" rowspan="1" colspan="1">miRNA name</th>
<th align="left" rowspan="1" colspan="1">Stability</th>
<th align="left" rowspan="1" colspan="1">Correlation with D14 injury score</th>
<th align="left" rowspan="1" colspan="1">Correlation with D14 skin perfusion</th>
<th align="left" rowspan="1" colspan="1">Component</th>
<th align="left" rowspan="1" colspan="1">miRNA name</th>
<th align="left" rowspan="1" colspan="1">Stability</th>
<th align="left" rowspan="1" colspan="1">Correlation with D14 injury score</th>
<th align="left" rowspan="1" colspan="1">Correlation with D14 skin perfusion</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="11" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">let-7d-3p</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="11" colspan="1">
<em>r</em> = 0.76<br>(<em>P</em> &lt; 0.0001)</td>
<td align="left" rowspan="11" colspan="1">
<em>r</em> = 0.15<br>(<em>P</em> = 0.32)</td>
<td align="left" rowspan="11" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">miR-186-5p</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="11" colspan="1">
<em>r</em> = 0.38<br>(<em>P</em> &lt; 0.05)</td>
<td align="left" rowspan="11" colspan="1">
<em>r</em> = −0.05<br>(<em>P</em> = 0.76)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-107</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">miR-92a-3p</td>
<td align="left" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-191-5p</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">miR-99b-5p</td>
<td align="left" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-19a-3p</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">let-7d-3p</td>
<td align="left" rowspan="1" colspan="1">0.88</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-208a-3p</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">miR-93-5p</td>
<td align="left" rowspan="1" colspan="1">0.82</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-24-3p</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">miR-10a-5p</td>
<td align="left" rowspan="1" colspan="1">0.76</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-29c-3p</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">miR-16-5p</td>
<td align="left" rowspan="1" colspan="1">0.74</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-652-3p</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">miR-324-3p</td>
<td align="left" rowspan="1" colspan="1">0.68</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-93-5p</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">miR-19a-3p</td>
<td align="left" rowspan="1" colspan="1">0.65</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-140-3p</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">miR-140-3p</td>
<td align="left" rowspan="1" colspan="1">0.62</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-139-5p</td>
<td align="left" rowspan="1" colspan="1">0.61</td>
<td align="left" rowspan="1" colspan="1">miR-872-3p</td>
<td align="left" rowspan="1" colspan="1">0.62</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">miR-92a-3p</td>
<td align="left" rowspan="1" colspan="1">0.67</td>
<td align="left" rowspan="2" colspan="1">
<em>r</em> = 0.01<br>(<em>P</em> = 0.93)</td>
<td align="left" rowspan="2" colspan="1">
<em>r</em> = 0.87<br>(<em>P</em> &lt; 0.01)</td>
<td align="left" rowspan="9" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">miR-139-5p</td>
<td align="left" rowspan="1" colspan="1">0.94</td>
<td align="left" rowspan="9" colspan="1">
<em>r</em> = −0.45<br>(<em>P</em> &lt; 0.05)</td>
<td align="left" rowspan="9" colspan="1">
<em>r</em> = −0.47<br>(<em>P</em> &lt; 0.05)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-324-3p</td>
<td align="left" rowspan="1" colspan="1">0.5</td>
<td align="left" rowspan="1" colspan="1">miR-93-5p</td>
<td align="left" rowspan="1" colspan="1">0.82</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">miR-744-5p</td>
<td align="left" rowspan="1" colspan="1">0.79</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">let-7d-3p</td>
<td align="left" rowspan="1" colspan="1">0.68</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">miR-19a-3p</td>
<td align="left" rowspan="1" colspan="1">0.65</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">miR-140-3p</td>
<td align="left" rowspan="1" colspan="1">0.62</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">miR-29c-3p</td>
<td align="left" rowspan="1" colspan="1">0.58</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">miR-375-3p</td>
<td align="left" rowspan="1" colspan="1">0.35</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">miR-340-5p</td>
<td align="left" rowspan="1" colspan="1">0.32</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0329737.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="pone.0329737.t002"><h4 class="obj_head">Table 2. Common miRNAs of D1 and D7 signatures with their putative functions.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">miRNA</th>
<th align="left" rowspan="1" colspan="1">Putative function</th>
<th align="left" rowspan="1" colspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">let-7d-3p</td>
<td align="left" rowspan="1" colspan="1">Potential inflammation biomarker in human subjects</td>
<td align="left" rowspan="1" colspan="1">[<a href="#pone.0329737.ref033" class="usa-link" aria-describedby="pone.0329737.ref033">33</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-139-5p</td>
<td align="left" rowspan="1" colspan="1">Regulation of inflammatory skin wound in mice</td>
<td align="left" rowspan="1" colspan="1">[<a href="#pone.0329737.ref034" class="usa-link" aria-describedby="pone.0329737.ref034">34</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-140-3p</td>
<td align="left" rowspan="1" colspan="1">Deregulated in bone marrow derived extracellular vesicles 24h after irradiation; Deregulated after gamma and X irradiation (chronic low dose rate, 3 Gy) in mice liver</td>
<td align="left" rowspan="1" colspan="1">[<a href="#pone.0329737.ref035" class="usa-link" aria-describedby="pone.0329737.ref035">35</a>,<a href="#pone.0329737.ref036" class="usa-link" aria-describedby="pone.0329737.ref036">36</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-16-5p</td>
<td align="left" rowspan="1" colspan="1">Inhibition of which led to significant reduction of inflammation and DNA double strand breaks in microvessel cells after space radiation simulation</td>
<td align="left" rowspan="1" colspan="1">[<a href="#pone.0329737.ref037" class="usa-link" aria-describedby="pone.0329737.ref037">37</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-19a-3p</td>
<td align="left" rowspan="1" colspan="1">Upregulation in rat blood 2 weeks after irradiation (whole thorax irradiation X rays)</td>
<td align="left" rowspan="1" colspan="1">[<a href="#pone.0329737.ref038" class="usa-link" aria-describedby="pone.0329737.ref038">38</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-29c-3p</td>
<td align="left" rowspan="1" colspan="1">Upregulate melanogenesis after UVB-irradiation of keratinocytes</td>
<td align="left" rowspan="1" colspan="1">[<a href="#pone.0329737.ref039" class="usa-link" aria-describedby="pone.0329737.ref039">39</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-324-3p</td>
<td align="left" rowspan="1" colspan="1">Related to inflammation and muscle inflammatory response</td>
<td align="left" rowspan="1" colspan="1">[<a href="#pone.0329737.ref040" class="usa-link" aria-describedby="pone.0329737.ref040">40</a>,<a href="#pone.0329737.ref041" class="usa-link" aria-describedby="pone.0329737.ref041">41</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-92a-3p</td>
<td align="left" rowspan="1" colspan="1">Upregulated in extracellular vesicles from healthy donors irradiated plasma (2Gy)</td>
<td align="left" rowspan="1" colspan="1">[<a href="#pone.0329737.ref042" class="usa-link" aria-describedby="pone.0329737.ref042">42</a>]</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR-93-5p</td>
<td align="left" rowspan="1" colspan="1">Improves radiosensitivity in breast cancer cells; Involved in inflammatory processes in murine skin lesion following UVB irradiation</td>
<td align="left" rowspan="1" colspan="1">[<a href="#pone.0329737.ref043" class="usa-link" aria-describedby="pone.0329737.ref043">43</a>,<a href="#pone.0329737.ref044" class="usa-link" aria-describedby="pone.0329737.ref044">44</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0329737.t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="sec022"><h2 class="pmc_sec_title">Discussion</h2>
<p>The absence of an early diagnostic tool for radiation burns delays appropriate medical care [<a href="#pone.0329737.ref001" class="usa-link" aria-describedby="pone.0329737.ref001">1</a>]. Radiation-induced skin damage vary in severity based on dose and can lead to tissue necrosis [<a href="#pone.0329737.ref045" class="usa-link" aria-describedby="pone.0329737.ref045">45</a>]. Advances in the field suggest that early treatment would improve therapeutic outcome [<a href="#pone.0329737.ref009" class="usa-link" aria-describedby="pone.0329737.ref009">9</a>], making it crucial to predict injury appearance and severity before the onset of the first symptoms. Omics approaches hold promise for identifying biomarkers, as molecular changes from irradiation likely precede clinical signs, providing relevant information on the evolution of a pathology [<a href="#pone.0329737.ref010" class="usa-link" aria-describedby="pone.0329737.ref010">10</a>,<a href="#pone.0329737.ref046" class="usa-link" aria-describedby="pone.0329737.ref046">46</a>]. MiRNAs have already been documented as being modulated in blood after irradiation in preclinical models of whole-body exposure [<a href="#pone.0329737.ref018" class="usa-link" aria-describedby="pone.0329737.ref018">18</a>,<a href="#pone.0329737.ref019" class="usa-link" aria-describedby="pone.0329737.ref019">19</a>,<a href="#pone.0329737.ref021" class="usa-link" aria-describedby="pone.0329737.ref021">21</a>,<a href="#pone.0329737.ref047" class="usa-link" aria-describedby="pone.0329737.ref047">47</a>–<a href="#pone.0329737.ref049" class="usa-link" aria-describedby="pone.0329737.ref049">49</a>], as well as in patient blood after radiotherapy [<a href="#pone.0329737.ref050" class="usa-link" aria-describedby="pone.0329737.ref050">50</a>,<a href="#pone.0329737.ref051" class="usa-link" aria-describedby="pone.0329737.ref051">51</a>]. In addition, we previously demonstrated the relevance of plasma miRNAs for the diagnosis of LRI in a mouse preclinical model [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>]. They are therefore excellent candidates for the search for minimally or non-invasive early prognosis biomarkers of radiation burns.</p>
<p>Clinical monitoring of mice demonstrated that, in our model, at D1 post-irradiation there was no evidence of injury whether looking at clinical or functional parameters, except for a decrease in circulating lymphocyte count, which could be the result of radiation-induced lymphocyte death or their recruitment in irradiated tissue [<a href="#pone.0329737.ref052" class="usa-link" aria-describedby="pone.0329737.ref052">52</a>]. However, this unique feature would be insufficient for the detection of irradiated mice since the decrease was only significant for the highest irradiation dose. Likewise, the other CBC parameters, plasma CRP levels and TEWL measurements did not inform about IR exposure for any dose group. At D7 post-irradiation, a minority of mice irradiated at 80 Gy started to show slight erythema, indicating the coming appearance of injury. Of note, these results are in agreement with our previous study where injury signs were not generally detected at D7 and could be observed by D10 post-irradiation [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>]. An increase in skin perfusion of irradiated limbs was also observed at D7 for mice exposed to highest doses, which was significant only for the 80 Gy group compared to unexposed controls. However this increase was not found in previous animal cohorts at this timepoint and therefore would not be relevant for LRI early diagnosis considering the variability of this analysis at this stage in our model [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>]. In addition, no modification of CBC, CRP levels or TEWL was detected between groups at D7. Therefore, at D1 and D7 there was no obvious sign of injury whether looking at clinical, functional or biological parameters that could effectively identify irradiated mice and estimate putative severity of exposure.</p>
<p>Thus, in our preclinical model, days 1 and 7 post-irradiation corresponded to early and late stages of the latency phase, respectively, and offered the possibility of studying sensitive, non-invasive miRNA biomarkers for the prediction of LRI onset and severity before first clinical manifestations.</p>
<p>Results of the broad-spectrum profiling analysis of plasma miRNAs at D1 post-irradiation led to the identification of a miRNA panel able to distinguish mice according to their dose group. Study of multi-scale correlations between individual values showed relevant correlations between some features of the identified panel and clinical or functional parameters (<em>e.g.,</em> lymphocyte counts and miR-208a-3p). This preliminary signature suggests that circulating miRNAs are suitable candidate biomarkers for a very early diagnosis of localized IR exposure. At D7 post-irradiation, although less robust compared to D1, the model obtained from multi-block analysis could identify a group of miRNAs able to segregate dose groups. Consequently, these broad-spectrum D1 and D7 analyses, besides D14 miRNAs signature, led to the selection of a miRNA panel used for the targeted study on 2 additional, independent D1 and D7 mouse cohorts.</p>
<p>Targeted analysis led to the identification of two early signatures, respectively identified at the beginning (D1, 14 miRNAs) and the end (D7, 16 miRNAs) of the presymptomatic latency phase, able to discriminate mice according to their dose group with great performances. Specifically, the signature identified at D1 showed good performances for the distinction of all groups from one another, with AUC values between 0.74 and 0.8 and significant <em>p</em>-values (&lt;0.05). Furthermore, this signature displayed a component with a particular contribution to the 80 Gy group segregation, characterized by the fall of lymphocyte counts at D1 post-irradiation. This was confirmed by the significant correlations identified between miRNA plasma expression levels and CBC parameters at D1 post-irradiation which revealed interesting associations between some miRNAs and lymphocyte levels, suggesting involvement of those miRNAs in inflammatory processes. Indeed, some miRNAs have already been identified in literature as inflammation biomarkers (let-7d-3p [<a href="#pone.0329737.ref033" class="usa-link" aria-describedby="pone.0329737.ref033">33</a>]) or key regulators (miR-324-3p [<a href="#pone.0329737.ref041" class="usa-link" aria-describedby="pone.0329737.ref041">41</a>], miR-93-5p [<a href="#pone.0329737.ref044" class="usa-link" aria-describedby="pone.0329737.ref044">44</a>]). Similarly, the identified D7 miRNA signature comprised two components which contributed more specifically to the separation of the higher dose groups (component 1) and of the lower dose groups (component 2). This 16-miRNA signature showed great performances for the segregation of each dose group from the others with AUC values ranging from 0.93 (<em>P</em> &lt; 0.01) for the 80 Gy group to 0.76 (<em>P</em> &lt; 0.05) for the control group. Seven days after irradiation some miRNA expression levels were still significantly related to lymphocyte and neutrophile counts, which suggests again a potential role of these miRNAs in inflammatory processes. Interestingly, some of those miRNAs were also related to lymphocyte counts at D1 post-irradiation (miR-324-3p, miR-93-5p, miR-140-3p) which suggests a potential interest in these miRNAs for the follow-up of inflammation during the first week after irradiation in this model.</p>
<p>These results demonstrate the relevance of using plasma miRNAs as early biomarkers of LRI. Indeed, we already showed that LRI severity increases with irradiation dose, which suggests that early, dose-associated miRNA signatures should also be related to expected injury severity. This point is supported by the Bayesian latent variable model which correlated the D1 and D7 signatures with injury scores and skin perfusion measured at D14 post-irradiation (manifestation phase) from our previous study [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>]. Furthermore, those two signatures share 9 common miRNAs (i.e., a majority within each signature), which paves the way for determining a single relevant signature able to predict LRI severity with samples collected during the latency phase. Eventually, an ideal signature would be informative during both LRI latency and manifestation phases, providing clue about severity, kinetics of injury development, healing potential and risk of resurgences. However, despite the fact that injury severity and irradiation dose are strongly correlated in our LRI model, they are not strictly overlapping. Indeed, we previously showed that mice irradiated at 40 Gy can display slight to severe injuries similar to animals from the 20 or 80 Gy group, depending on each animal and on the analyzed timepoint [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>]. Further studies looking at early miRNA biomarkers during the latency phase that would relate to injury severity at later timepoints in the same animal should improve the performances of the signatures described in the present paper for prognosis of LRI appearance and severity.</p>
<p>Among the 9 common miRNAs of the two signatures, miR-139-5p was also part of the diagnostic plasma signature previously identified at D14 post-irradiation (manifestation phase) [<a href="#pone.0329737.ref026" class="usa-link" aria-describedby="pone.0329737.ref026">26</a>]. This miRNA was also already identified as a regulator of inflammatory response in a model of bacteria infected skin wound healing [<a href="#pone.0329737.ref034" class="usa-link" aria-describedby="pone.0329737.ref034">34</a>]. Interestingly, a majority of those 9 miRNAs have previously been identified as being modulated in response to IR in several preclinical studies. Notably, miR-19a-3p was found upregulated in rat blood 2 weeks after whole thorax irradiation using X rays [<a href="#pone.0329737.ref038" class="usa-link" aria-describedby="pone.0329737.ref038">38</a>], while miR-140-3p was shown deregulated in extracellular vesicles derived from bone marrow 24h after irradiation [<a href="#pone.0329737.ref036" class="usa-link" aria-describedby="pone.0329737.ref036">36</a>] and in mice liver after chronic, low-dose rate gamma and X irradiation [<a href="#pone.0329737.ref035" class="usa-link" aria-describedby="pone.0329737.ref035">35</a>]. In addition, miR-92a-3p was deregulated in exosomes from irradiated plasma of healthy donors [<a href="#pone.0329737.ref042" class="usa-link" aria-describedby="pone.0329737.ref042">42</a>]. Furthermore, a recent study showed that antagomir-mediated inhibition of miR-16-5p led to significant reduction of inflammation and DNA double strand breaks in human microvascular cells exposed to simulated space radiation conditions [<a href="#pone.0329737.ref037" class="usa-link" aria-describedby="pone.0329737.ref037">37</a>]. Other miRNAs are related to inflammation, including let-7d-3p which is a potential inflammation biomarker in human subjects [<a href="#pone.0329737.ref033" class="usa-link" aria-describedby="pone.0329737.ref033">33</a>] and miR-324-3p which is known to be involved in inflammation processes and notably in muscular inflammatory conditions [<a href="#pone.0329737.ref040" class="usa-link" aria-describedby="pone.0329737.ref040">40</a>,<a href="#pone.0329737.ref041" class="usa-link" aria-describedby="pone.0329737.ref041">41</a>]. Finally, miR-29c-3p has been discovered as an up-regulator of melanogenesis after UVB-irradiation in keratinocytes [<a href="#pone.0329737.ref039" class="usa-link" aria-describedby="pone.0329737.ref039">39</a>]. All this information is interesting when considering that inflammation, and skin and muscle damage are part of LRI pathophysiology and therefore support the relevance of signatures whose components could be part of molecular alterations.</p></section><section id="sec023"><h2 class="pmc_sec_title">Conclusions</h2>
<p>In conclusion, this study provided the first plasma miRNA signature as early biomarkers of LRI, able to segregate animals according to dose groups during the presymptomatic, latency phase. Two signatures were identified at early and late stages of latency, sharing a majority of miRNAs known to be involved in molecular pathways of LRI pathophysiology. These results pave the way for the identification of a unique plasma miRNA signature able to predict LRI onset and severity during the whole latency phase, thereby contributing to enriching the diagnostic arsenal of LRI. Such molecular tool would be crucial for medical triage during a nuclear or radiological event and would improve medical care for patients. However, the robustness of such signature must be challenged using other preclinical models including large animals, as well as on female subjects.</p></section><section id="sec024"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0329737.s001"><div class="caption p">
<span>S1 Fig. CBC at D1 post-irradiation.</span><p>Each animal is represented (n = 13–15/group). Kruskal-Wallis analysis, * <em>P</em> &lt; 0.05; *** <em>P</em> &lt; 0.001; **** <em>P</em> &lt; 0.0001. RBC, red blood cells; Hb, hemoglobin; Ht, hematocrit; PLT, platelet; WBC, white blood cells; NEU, neutrophils; LYM, lymphocytes; MCHC, Mean corpuscular hemoglobin concentration; MCH, mean corpuscular hemoglobin; MONO, monocytes.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s001.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s001.tif</a><sup> (437.7KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0329737.s002"><div class="caption p">
<span>S2 Fig. CBC at D7 post-irradiation.</span><p>Each animal is represented (n = 12–15/group). Kruskal-Wallis analysis.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s002.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s002.tif</a><sup> (464.2KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0329737.s003"><div class="caption p">
<span>S3 Table. Raw data for each cohort of the study.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s003.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s003.xlsx</a><sup> (299.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0329737.s004"><div class="caption p">
<span>S4 Table. Raw data of QC miRNAs and controls for each cohort.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s004.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s004.xlsx</a><sup> (19.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0329737.s005"><div class="caption p">
<span>S5 Table. Injury scores and laser Doppler skin perfusion ratios (IRR/NIR) at day-14 (from ref26).</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s005.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s005.xlsx</a><sup> (12.7KB, xlsx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors wish to thank D. Denais-Lalieve, F. Voyer, R. Granger and A. Sache, for assistance with animal housing and handling. The authors thank M. Razanajatovo and Y. Ristic for their help with irradiation on the Elekta Synergy Platform. The authors wish to thank Emmanuelle Guillot-Combe for her support and advice.</p></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>All relevant data are within the paper and its <a href="#sec024" class="usa-link">Supporting Information</a> files.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This work was supported by IRSN (ASNR since 01/01/2025), Electricité de France EDF (Groupe Gestion Projet Radioprotection, grant V2-303) and the ANR-Astrid program from the Defence Innovation Agency (AID) of the French Armed Forces Ministry grant ANR-22-ASTR-0028 (M.S., M.A.B. and S.F.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0329737.ref001">
<span class="label">1.</span><cite>WHO. National stockpiles for radiological and nuclear emergencies: policy advice. Geneva: World Health Organization, Licence: CC BY-NC-SA 3.0 IGO. 2023.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=National%20stockpiles%20for%20radiological%20and%20nuclear%20emergencies:%20policy%20advice&amp;publication_year=2023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref002">
<span class="label">2.</span><cite>IAEA. Medical Management of Radiation Injuries, Safety Reports Series No. 101. Vienna: International Atomic Energy Agency, 2020.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Medical%20Management%20of%20Radiation%20Injuries,%20Safety%20Reports%20Series%20No.%20101&amp;publication_year=2020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref003">
<span class="label">3.</span><cite>Iddins CJ, DiCarlo AL, Ervin MD, Herrera-Reyes E, Goans RE. Cutaneous and local radiation injuries. J Radiol Prot. 2022;42(1):10.1088/1361-6498/ac241a. doi: 10.1088/1361-6498/ac241a

</cite> [<a href="https://doi.org/10.1088/1361-6498/ac241a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8785213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34488201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Radiol%20Prot&amp;title=Cutaneous%20and%20local%20radiation%20injuries&amp;author=CJ%20Iddins&amp;author=AL%20DiCarlo&amp;author=MD%20Ervin&amp;author=E%20Herrera-Reyes&amp;author=RE%20Goans&amp;volume=42&amp;issue=1&amp;publication_year=2022&amp;pmid=34488201&amp;doi=10.1088/1361-6498/ac241a&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref004">
<span class="label">4.</span><cite>Bray FN, Simmons BJ, Wolfson AH, Nouri K. Acute and Chronic Cutaneous Reactions to Ionizing Radiation Therapy. Dermatol Ther (Heidelb). 2016;6(2):185–206. doi: 10.1007/s13555-016-0120-y

</cite> [<a href="https://doi.org/10.1007/s13555-016-0120-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4906114/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27250839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dermatol%20Ther%20(Heidelb)&amp;title=Acute%20and%20Chronic%20Cutaneous%20Reactions%20to%20Ionizing%20Radiation%20Therapy&amp;author=FN%20Bray&amp;author=BJ%20Simmons&amp;author=AH%20Wolfson&amp;author=K%20Nouri&amp;volume=6&amp;issue=2&amp;publication_year=2016&amp;pages=185-206&amp;pmid=27250839&amp;doi=10.1007/s13555-016-0120-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref005">
<span class="label">5.</span><cite>Brown KR, Rzucidlo E. Acute and chronic radiation injury. J Vasc Surg. 2011;53(1 Suppl):15S-21S. doi: 10.1016/j.jvs.2010.06.175

</cite> [<a href="https://doi.org/10.1016/j.jvs.2010.06.175" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20843630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Vasc%20Surg&amp;title=Acute%20and%20chronic%20radiation%20injury&amp;author=KR%20Brown&amp;author=E%20Rzucidlo&amp;volume=53&amp;publication_year=2011&amp;pmid=20843630&amp;doi=10.1016/j.jvs.2010.06.175&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref006">
<span class="label">6.</span><cite>Mendelsohn FA, Divino CM, Reis ED, Kerstein MD. Wound care after radiation therapy. Adv Skin Wound Care. 2002;15(5):216–24. doi: 10.1097/00129334-200209000-00007

</cite> [<a href="https://doi.org/10.1097/00129334-200209000-00007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12368711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Skin%20Wound%20Care&amp;title=Wound%20care%20after%20radiation%20therapy&amp;author=FA%20Mendelsohn&amp;author=CM%20Divino&amp;author=ED%20Reis&amp;author=MD%20Kerstein&amp;volume=15&amp;issue=5&amp;publication_year=2002&amp;pages=216-24&amp;pmid=12368711&amp;doi=10.1097/00129334-200209000-00007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref007">
<span class="label">7.</span><cite>Wolbarst AB, Wiley AL Jr, Nemhauser JB, Christensen DM, Hendee WR. Medical response to a major radiologic emergency: a primer for medical and public health practitioners. Radiology. 2010;254(3):660–77. doi: 10.1148/radiol.09090330

</cite> [<a href="https://doi.org/10.1148/radiol.09090330" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20177084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Medical%20response%20to%20a%20major%20radiologic%20emergency:%20a%20primer%20for%20medical%20and%20public%20health%20practitioners&amp;author=AB%20Wolbarst&amp;author=Jr%20Wiley%20AL&amp;author=JB%20Nemhauser&amp;author=DM%20Christensen&amp;author=WR%20Hendee&amp;volume=254&amp;issue=3&amp;publication_year=2010&amp;pages=660-77&amp;pmid=20177084&amp;doi=10.1148/radiol.09090330&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref008">
<span class="label">8.</span><cite>Bey E, Prat M, Duhamel P, Benderitter M, Brachet M, Trompier F, et al. Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen. 2010;18(1):50–8. doi: 10.1111/j.1524-475X.2009.00562.x

</cite> [<a href="https://doi.org/10.1111/j.1524-475X.2009.00562.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20082681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Wound%20Repair%20Regen&amp;title=Emerging%20therapy%20for%20improving%20wound%20repair%20of%20severe%20radiation%20burns%20using%20local%20bone%20marrow-derived%20stem%20cell%20administrations&amp;author=E%20Bey&amp;author=M%20Prat&amp;author=P%20Duhamel&amp;author=M%20Benderitter&amp;author=M%20Brachet&amp;volume=18&amp;issue=1&amp;publication_year=2010&amp;pages=50-8&amp;pmid=20082681&amp;doi=10.1111/j.1524-475X.2009.00562.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref009">
<span class="label">9.</span><cite>Lataillade JJ, Doucet C, Bey E, Carsin H, Huet C, Clairand I, et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regenerative Medicine. 2007;2(5):785–94.
</cite> [<a href="https://doi.org/10.2217/17460751.2.5.785" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17907931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Regenerative%20Medicine&amp;title=New%20approach%20to%20radiation%20burn%20treatment%20by%20dosimetry-guided%20surgery%20combined%20with%20autologous%20mesenchymal%20stem%20cell%20therapy&amp;author=JJ%20Lataillade&amp;author=C%20Doucet&amp;author=E%20Bey&amp;author=H%20Carsin&amp;author=C%20Huet&amp;volume=2&amp;issue=5&amp;publication_year=2007&amp;pages=785-94&amp;pmid=17907931&amp;doi=10.2217/17460751.2.5.785&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref010">
<span class="label">10.</span><cite>Chen R, Snyder M. Promise of personalized omics to precision medicine. Wiley Interdiscip Rev Syst Biol Med. 2013;5(1):73–82. doi: 10.1002/wsbm.1198

</cite> [<a href="https://doi.org/10.1002/wsbm.1198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4154620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23184638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Wiley%20Interdiscip%20Rev%20Syst%20Biol%20Med&amp;title=Promise%20of%20personalized%20omics%20to%20precision%20medicine&amp;author=R%20Chen&amp;author=M%20Snyder&amp;volume=5&amp;issue=1&amp;publication_year=2013&amp;pages=73-82&amp;pmid=23184638&amp;doi=10.1002/wsbm.1198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref011">
<span class="label">11.</span><cite>DiCarlo AL, Bandremer AC, Hollingsworth BA, Kasim S, Laniyonu A, Todd NF. Cutaneous Radiation Injuries: Models, Assessment and Treatments. Radiat Res. 2020;194(3):315–44.
</cite> [<a href="https://doi.org/10.1667/RADE-20-00120.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7525796/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32857831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiat%20Res&amp;title=Cutaneous%20Radiation%20Injuries:%20Models,%20Assessment%20and%20Treatments&amp;author=AL%20DiCarlo&amp;author=AC%20Bandremer&amp;author=BA%20Hollingsworth&amp;author=S%20Kasim&amp;author=A%20Laniyonu&amp;volume=194&amp;issue=3&amp;publication_year=2020&amp;pages=315-44&amp;pmid=32857831&amp;doi=10.1667/RADE-20-00120.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref012">
<span class="label">12.</span><cite>Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997–1006. doi: 10.1038/cr.2008.282

</cite> [<a href="https://doi.org/10.1038/cr.2008.282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18766170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Res&amp;title=Characterization%20of%20microRNAs%20in%20serum:%20a%20novel%20class%20of%20biomarkers%20for%20diagnosis%20of%20cancer%20and%20other%20diseases&amp;author=X%20Chen&amp;author=Y%20Ba&amp;author=L%20Ma&amp;author=X%20Cai&amp;author=Y%20Yin&amp;volume=18&amp;issue=10&amp;publication_year=2008&amp;pages=997-1006&amp;pmid=18766170&amp;doi=10.1038/cr.2008.282&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref013">
<span class="label">13.</span><cite>Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(30):10513–8.
</cite> [<a href="https://doi.org/10.1073/pnas.0804549105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2492472/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18663219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America&amp;title=Circulating%20microRNAs%20as%20stable%20blood-based%20markers%20for%20cancer%20detection&amp;author=PS%20Mitchell&amp;author=RK%20Parkin&amp;author=EM%20Kroh&amp;author=BR%20Fritz&amp;author=SK%20Wyman&amp;volume=105&amp;issue=30&amp;publication_year=2008&amp;pages=10513-8&amp;pmid=18663219&amp;doi=10.1073/pnas.0804549105&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref014">
<span class="label">14.</span><cite>Sundarbose K, Kartha RV, Subramanian S. MicroRNAs as Biomarkers in Cancer. Diagnostics (Basel). 2013;3(1):84–104. doi: 10.3390/diagnostics3010084

</cite> [<a href="https://doi.org/10.3390/diagnostics3010084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4665585/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26835669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostics%20(Basel)&amp;title=MicroRNAs%20as%20Biomarkers%20in%20Cancer&amp;author=K%20Sundarbose&amp;author=RV%20Kartha&amp;author=S%20Subramanian&amp;volume=3&amp;issue=1&amp;publication_year=2013&amp;pages=84-104&amp;pmid=26835669&amp;doi=10.3390/diagnostics3010084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref015">
<span class="label">15.</span><cite>Fang L, Ellims AH, Moore X, White DA, Taylor AJ, Chin-Dusting J, et al. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med. 2015;13:314. doi: 10.1186/s12967-015-0672-0

</cite> [<a href="https://doi.org/10.1186/s12967-015-0672-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4581079/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26404540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Transl%20Med&amp;title=Circulating%20microRNAs%20as%20biomarkers%20for%20diffuse%20myocardial%20fibrosis%20in%20patients%20with%20hypertrophic%20cardiomyopathy&amp;author=L%20Fang&amp;author=AH%20Ellims&amp;author=X%20Moore&amp;author=DA%20White&amp;author=AJ%20Taylor&amp;volume=13&amp;publication_year=2015&amp;pages=314&amp;pmid=26404540&amp;doi=10.1186/s12967-015-0672-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref016">
<span class="label">16.</span><cite>Ichihara A, Wang Z, Jinnin M, Izuno Y, Shimozono N, Yamane K, et al. Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions. J Allergy Clin Immunol. 2014;133(4):1065–74. doi: 10.1016/j.jaci.2013.09.019

</cite> [<a href="https://doi.org/10.1016/j.jaci.2013.09.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24184144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Allergy%20Clin%20Immunol&amp;title=Upregulation%20of%20miR-18a-5p%20contributes%20to%20epidermal%20necrolysis%20in%20severe%20drug%20eruptions&amp;author=A%20Ichihara&amp;author=Z%20Wang&amp;author=M%20Jinnin&amp;author=Y%20Izuno&amp;author=N%20Shimozono&amp;volume=133&amp;issue=4&amp;publication_year=2014&amp;pages=1065-74&amp;pmid=24184144&amp;doi=10.1016/j.jaci.2013.09.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref017">
<span class="label">17.</span><cite>Sato S, Ichihara A, Jinnin M, Izuno Y, Fukushima S, Ihn H. Serum miR-124 up-regulation as a disease marker of toxic epidermal necrolysis. Eur J Dermatol. 2015;25(5):457–62.
</cite> [<a href="https://doi.org/10.1684/ejd.2015.2621" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26394757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Dermatol&amp;title=Serum%20miR-124%20up-regulation%20as%20a%20disease%20marker%20of%20toxic%20epidermal%20necrolysis&amp;author=S%20Sato&amp;author=A%20Ichihara&amp;author=M%20Jinnin&amp;author=Y%20Izuno&amp;author=S%20Fukushima&amp;volume=25&amp;issue=5&amp;publication_year=2015&amp;pages=457-62&amp;pmid=26394757&amp;doi=10.1684/ejd.2015.2621&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref018">
<span class="label">18.</span><cite>Chakraborty N, Gautam A, Holmes-Hampton GP, Kumar VP, Biswas S, Kumar R, et al. microRNA and Metabolite Signatures Linked to Early Consequences of Lethal Radiation. Sci Rep. 2020;10(1):5424. doi: 10.1038/s41598-020-62255-w

</cite> [<a href="https://doi.org/10.1038/s41598-020-62255-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7096415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32214144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=microRNA%20and%20Metabolite%20Signatures%20Linked%20to%20Early%20Consequences%20of%20Lethal%20Radiation&amp;author=N%20Chakraborty&amp;author=A%20Gautam&amp;author=GP%20Holmes-Hampton&amp;author=VP%20Kumar&amp;author=S%20Biswas&amp;volume=10&amp;issue=1&amp;publication_year=2020&amp;pages=5424&amp;pmid=32214144&amp;doi=10.1038/s41598-020-62255-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref019">
<span class="label">19.</span><cite>Jia M, Wang Z. MicroRNAs as Biomarkers for Ionizing Radiation Injury. Front Cell Dev Biol. 2022;10:861451. doi: 10.3389/fcell.2022.861451

</cite> [<a href="https://doi.org/10.3389/fcell.2022.861451" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8927810/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35309926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cell%20Dev%20Biol&amp;title=MicroRNAs%20as%20Biomarkers%20for%20Ionizing%20Radiation%20Injury&amp;author=M%20Jia&amp;author=Z%20Wang&amp;volume=10&amp;publication_year=2022&amp;pages=861451&amp;pmid=35309926&amp;doi=10.3389/fcell.2022.861451&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref020">
<span class="label">20.</span><cite>Li J, Shen Z, Chen W, Feng Z, Fang L, Zhao J, et al. Screening of miRNAs in White Blood Cell as a Radiation Biomarkers for Rapid Assessment of Acute Radiation Injury. Dose Response. 2022;20(3):15593258221123679. doi: 10.1177/15593258221123679

</cite> [<a href="https://doi.org/10.1177/15593258221123679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9483971/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36132708/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dose%20Response&amp;title=Screening%20of%20miRNAs%20in%20White%20Blood%20Cell%20as%20a%20Radiation%20Biomarkers%20for%20Rapid%20Assessment%20of%20Acute%20Radiation%20Injury&amp;author=J%20Li&amp;author=Z%20Shen&amp;author=W%20Chen&amp;author=Z%20Feng&amp;author=L%20Fang&amp;volume=20&amp;issue=3&amp;publication_year=2022&amp;pages=15593258221123679&amp;pmid=36132708&amp;doi=10.1177/15593258221123679&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref021">
<span class="label">21.</span><cite>Wei W, He J, Wang J, Ding N, Wang B, Lin S, et al. Serum microRNAs as Early Indicators for Estimation of Exposure Degree in Response to Ionizing Irradiation. Radiat Res. 2017;188(3):342–54. doi: 10.1667/RR14702.1

</cite> [<a href="https://doi.org/10.1667/RR14702.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28632432/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiat%20Res&amp;title=Serum%20microRNAs%20as%20Early%20Indicators%20for%20Estimation%20of%20Exposure%20Degree%20in%20Response%20to%20Ionizing%20Irradiation&amp;author=W%20Wei&amp;author=J%20He&amp;author=J%20Wang&amp;author=N%20Ding&amp;author=B%20Wang&amp;volume=188&amp;issue=3&amp;publication_year=2017&amp;pages=342-54&amp;pmid=28632432&amp;doi=10.1667/RR14702.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref022">
<span class="label">22.</span><cite>Yadav M, Bhayana S, Liu J, Lu L, Huang J, Ma Y, et al. Two-miRNA-based finger-stick assay for estimation of absorbed ionizing radiation dose. Sci Transl Med. 2020;12(552):eaaw5831. doi: 10.1126/scitranslmed.aaw5831

</cite> [<a href="https://doi.org/10.1126/scitranslmed.aaw5831" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8501214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32669422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Transl%20Med&amp;title=Two-miRNA-based%20finger-stick%20assay%20for%20estimation%20of%20absorbed%20ionizing%20radiation%20dose&amp;author=M%20Yadav&amp;author=S%20Bhayana&amp;author=J%20Liu&amp;author=L%20Lu&amp;author=J%20Huang&amp;volume=12&amp;issue=552&amp;publication_year=2020&amp;pmid=32669422&amp;doi=10.1126/scitranslmed.aaw5831&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref023">
<span class="label">23.</span><cite>Rogers CJ, Lukaszewicz AI, Yamada-Hanff J, Micewicz ED, Ratikan JA, Starbird MA, et al. Identification of miRNA signatures associated with radiation-induced late lung injury in mice. PLoS One. 2020;15(5):e0232411. doi: 10.1371/journal.pone.0232411

</cite> [<a href="https://doi.org/10.1371/journal.pone.0232411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7213687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32392259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Identification%20of%20miRNA%20signatures%20associated%20with%20radiation-induced%20late%20lung%20injury%20in%20mice&amp;author=CJ%20Rogers&amp;author=AI%20Lukaszewicz&amp;author=J%20Yamada-Hanff&amp;author=ED%20Micewicz&amp;author=JA%20Ratikan&amp;volume=15&amp;issue=5&amp;publication_year=2020&amp;pmid=32392259&amp;doi=10.1371/journal.pone.0232411&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref024">
<span class="label">24.</span><cite>Rogers CJ, Kyubwa EM, Lukaszewicz AI, Starbird MA, Nguyen M, Copeland BT, et al. Observation of Unique Circulating miRNA Signatures in Non-Human Primates Exposed to Total-Body vs. Whole Thorax Lung Irradiation. Radiat Res. 2021;196(5):547–59. doi: 10.1667/RADE-21-00043.1

</cite> [<a href="https://doi.org/10.1667/RADE-21-00043.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34525208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiat%20Res&amp;title=Observation%20of%20Unique%20Circulating%20miRNA%20Signatures%20in%20Non-Human%20Primates%20Exposed%20to%20Total-Body%20vs.%20Whole%20Thorax%20Lung%20Irradiation&amp;author=CJ%20Rogers&amp;author=EM%20Kyubwa&amp;author=AI%20Lukaszewicz&amp;author=MA%20Starbird&amp;author=M%20Nguyen&amp;volume=196&amp;issue=5&amp;publication_year=2021&amp;pages=547-59&amp;pmid=34525208&amp;doi=10.1667/RADE-21-00043.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref025">
<span class="label">25.</span><cite>Simone BA, Ly D, Savage JE, Hewitt SM, Dan TD, Ylaya K, et al. microRNA alterations driving acute and late stages of radiation-induced fibrosis in a murine skin model. Int J Radiat Oncol Biol Phys. 2014;90(1):44–52. doi: 10.1016/j.ijrobp.2014.05.003

</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2014.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7665809/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24986745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;title=microRNA%20alterations%20driving%20acute%20and%20late%20stages%20of%20radiation-induced%20fibrosis%20in%20a%20murine%20skin%20model&amp;author=BA%20Simone&amp;author=D%20Ly&amp;author=JE%20Savage&amp;author=SM%20Hewitt&amp;author=TD%20Dan&amp;volume=90&amp;issue=1&amp;publication_year=2014&amp;pages=44-52&amp;pmid=24986745&amp;doi=10.1016/j.ijrobp.2014.05.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref026">
<span class="label">26.</span><cite>Ancel L, Gabillot O, Szurewsky C, Granger R, Sache A, Voyer F, et al. MicroRNA blood signature for localized radiation injury. Sci Rep. 2024;14(1):2681.
</cite> [<a href="https://doi.org/10.1038/s41598-024-52258-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10834964/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38302506/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=MicroRNA%20blood%20signature%20for%20localized%20radiation%20injury&amp;author=L%20Ancel&amp;author=O%20Gabillot&amp;author=C%20Szurewsky&amp;author=R%20Granger&amp;author=A%20Sache&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pages=2681&amp;pmid=38302506&amp;doi=10.1038/s41598-024-52258-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref027">
<span class="label">27.</span><cite>Ancel L, Grison S, Gabillot O, Gueguen J, Svilar L, Guen BL, et al. Metabolomics identifies plasma biomarkers of localized radiation injury. Sci Rep. 2025;15(1):2166. doi: 10.1038/s41598-025-85717-5

</cite> [<a href="https://doi.org/10.1038/s41598-025-85717-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11739571/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39819895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Metabolomics%20identifies%20plasma%20biomarkers%20of%20localized%20radiation%20injury&amp;author=L%20Ancel&amp;author=S%20Grison&amp;author=O%20Gabillot&amp;author=J%20Gueguen&amp;author=L%20Svilar&amp;volume=15&amp;issue=1&amp;publication_year=2025&amp;pages=2166&amp;pmid=39819895&amp;doi=10.1038/s41598-025-85717-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref028">
<span class="label">28.</span><cite>Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59(1):S1-6. doi: 10.1016/j.ymeth.2012.09.015

</cite> [<a href="https://doi.org/10.1016/j.ymeth.2012.09.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23036329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods&amp;title=Assessing%20sample%20and%20miRNA%20profile%20quality%20in%20serum%20and%20plasma%20or%20other%20biofluids&amp;author=T%20Blondal&amp;author=S%20Jensby%20Nielsen&amp;author=A%20Baker&amp;author=D%20Andreasen&amp;author=P%20Mouritzen&amp;volume=59&amp;issue=1&amp;publication_year=2013&amp;pmid=23036329&amp;doi=10.1016/j.ymeth.2012.09.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref029">
<span class="label">29.</span><cite>Zhu Y, Zhao A. MiRAnorm: Adaptive Normalization for miRNA Data version 1.0.0 from CRAN. 2016 [updated 2025/01/23/12:39:21]. <a href="https://rdrr.io/cran/MiRAnorm/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://rdrr.io/cran/MiRAnorm/</a></cite>
</li>
<li id="pone.0329737.ref030">
<span class="label">30.</span><cite>Singh A, Shannon CP, Gautier B, Rohart F, Vacher M, Tebbutt SJ, et al. DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays. Bioinformatics. 2019;35(17):3055–62. doi: 10.1093/bioinformatics/bty1054

</cite> [<a href="https://doi.org/10.1093/bioinformatics/bty1054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6735831/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30657866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=DIABLO:%20an%20integrative%20approach%20for%20identifying%20key%20molecular%20drivers%20from%20multi-omics%20assays&amp;author=A%20Singh&amp;author=CP%20Shannon&amp;author=B%20Gautier&amp;author=F%20Rohart&amp;author=M%20Vacher&amp;volume=35&amp;issue=17&amp;publication_year=2019&amp;pages=3055-62&amp;pmid=30657866&amp;doi=10.1093/bioinformatics/bty1054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref031">
<span class="label">31.</span><cite>Song XY, Lee SY. Basic and Advanced Bayesian Structural Equation Modeling: With Applications in the Medical and Behavioral Sciences. Chichester, West Sussex: John Wiley &amp; Sons, Ltd. 2012.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Basic%20and%20Advanced%20Bayesian%20Structural%20Equation%20Modeling:%20With%20Applications%20in%20the%20Medical%20and%20Behavioral%20Sciences&amp;author=XY%20Song&amp;author=SY%20Lee&amp;publication_year=2012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref032">
<span class="label">32.</span><cite>Plummer M. JAGS: A Program for Analysis of Bayesian Graphical Models using Gibbs Sampling. 3rd International Workshop on Distributed Statistical Computing; Vienna, Austria; 2003.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=JAGS:%20A%20Program%20for%20Analysis%20of%20Bayesian%20Graphical%20Models%20using%20Gibbs%20Sampling&amp;author=M%20Plummer&amp;publication_year=2003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref033">
<span class="label">33.</span><cite>Zhang Z, Luo H, Li C, Liang Z. Evidence for the circulating microRNA hsa-let-7d-3p as a potential new biomarker for sepsis in human subjects. Eur J Med Res. 2022;27(1):137. doi: 10.1186/s40001-022-00763-3

</cite> [<a href="https://doi.org/10.1186/s40001-022-00763-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9338616/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35907902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Med%20Res&amp;title=Evidence%20for%20the%20circulating%20microRNA%20hsa-let-7d-3p%20as%20a%20potential%20new%20biomarker%20for%20sepsis%20in%20human%20subjects&amp;author=Z%20Zhang&amp;author=H%20Luo&amp;author=C%20Li&amp;author=Z%20Liang&amp;volume=27&amp;issue=1&amp;publication_year=2022&amp;pages=137&amp;pmid=35907902&amp;doi=10.1186/s40001-022-00763-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref034">
<span class="label">34.</span><cite>Zhang W, Qu X, Zhu Z, Wang L, Qi Q, Zhou P, et al. Inhibition of miR-139-5p by topical JTXK gel promotes healing of Staphylococcus aureus-infected skin wounds. Cells Dev. 2021;166:203658. doi: 10.1016/j.cdev.2021.203658

</cite> [<a href="https://doi.org/10.1016/j.cdev.2021.203658" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33994349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells%20Dev&amp;title=Inhibition%20of%20miR-139-5p%20by%20topical%20JTXK%20gel%20promotes%20healing%20of%20Staphylococcus%20aureus-infected%20skin%20wounds&amp;author=W%20Zhang&amp;author=X%20Qu&amp;author=Z%20Zhu&amp;author=L%20Wang&amp;author=Q%20Qi&amp;volume=166&amp;publication_year=2021&amp;pages=203658&amp;pmid=33994349&amp;doi=10.1016/j.cdev.2021.203658&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref035">
<span class="label">35.</span><cite>Duale N, Eide DM, Amberger ML, Graupner A, Brede DA, Olsen AK. Using prediction models to identify miRNA-based markers of low dose rate chronic stress. Sci Total Environ. 2020;717:137068. doi: 10.1016/j.scitotenv.2020.137068

</cite> [<a href="https://doi.org/10.1016/j.scitotenv.2020.137068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32062256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Total%20Environ&amp;title=Using%20prediction%20models%20to%20identify%20miRNA-based%20markers%20of%20low%20dose%20rate%20chronic%20stress&amp;author=N%20Duale&amp;author=DM%20Eide&amp;author=ML%20Amberger&amp;author=A%20Graupner&amp;author=DA%20Brede&amp;volume=717&amp;publication_year=2020&amp;pages=137068&amp;pmid=32062256&amp;doi=10.1016/j.scitotenv.2020.137068&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref036">
<span class="label">36.</span><cite>Kis D, Csordás IB, Persa E, Jezsó B, Hargitai R, Szatmári T, et al. Extracellular Vesicles Derived from Bone Marrow in an Early Stage of Ionizing Radiation Damage Are Able to Induce Bystander Responses in the Bone Marrow. Cells. 2022;11(1):155. doi: 10.3390/cells11010155

</cite> [<a href="https://doi.org/10.3390/cells11010155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8750882/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35011718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Extracellular%20Vesicles%20Derived%20from%20Bone%20Marrow%20in%20an%20Early%20Stage%20of%20Ionizing%20Radiation%20Damage%20Are%20Able%20to%20Induce%20Bystander%20Responses%20in%20the%20Bone%20Marrow&amp;author=D%20Kis&amp;author=IB%20Csord%C3%A1s&amp;author=E%20Persa&amp;author=B%20Jezs%C3%B3&amp;author=R%20Hargitai&amp;volume=11&amp;issue=1&amp;publication_year=2022&amp;pages=155&amp;pmid=35011718&amp;doi=10.3390/cells11010155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref037">
<span class="label">37.</span><cite>McDonald JT, Kim J, Farmerie L, Johnson ML, Trovao NS, Arif S, et al. Space radiation damage rescued by inhibition of key spaceflight associated miRNAs. Nat Commun. 2024;15(1):4825. doi: 10.1038/s41467-024-48920-y

</cite> [<a href="https://doi.org/10.1038/s41467-024-48920-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11166944/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38862542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Space%20radiation%20damage%20rescued%20by%20inhibition%20of%20key%20spaceflight%20associated%20miRNAs&amp;author=JT%20McDonald&amp;author=J%20Kim&amp;author=L%20Farmerie&amp;author=ML%20Johnson&amp;author=NS%20Trovao&amp;volume=15&amp;issue=1&amp;publication_year=2024&amp;pages=4825&amp;pmid=38862542&amp;doi=10.1038/s41467-024-48920-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref038">
<span class="label">38.</span><cite>Gao F, Liu P, Narayanan J, Yang M, Fish BL, Liu Y, et al. Changes in miRNA in the lung and whole blood after whole thorax irradiation in rats. Sci Rep. 2017;7:44132. doi: 10.1038/srep44132

</cite> [<a href="https://doi.org/10.1038/srep44132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5355888/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28303893/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Changes%20in%20miRNA%20in%20the%20lung%20and%20whole%20blood%20after%20whole%20thorax%20irradiation%20in%20rats&amp;author=F%20Gao&amp;author=P%20Liu&amp;author=J%20Narayanan&amp;author=M%20Yang&amp;author=BL%20Fish&amp;volume=7&amp;publication_year=2017&amp;pages=44132&amp;pmid=28303893&amp;doi=10.1038/srep44132&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref039">
<span class="label">39.</span><cite>Yoon J-H, Jo C-S, Hwang J-S. Comprehensive Analysis of Exosomal MicroRNAs Derived from UVB-Irradiated Keratinocytes as Potential Melanogenesis Regulators. Int J Mol Sci. 2024;25(6):3095. doi: 10.3390/ijms25063095

</cite> [<a href="https://doi.org/10.3390/ijms25063095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10970293/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38542076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Comprehensive%20Analysis%20of%20Exosomal%20MicroRNAs%20Derived%20from%20UVB-Irradiated%20Keratinocytes%20as%20Potential%20Melanogenesis%20Regulators&amp;author=J-H%20Yoon&amp;author=C-S%20Jo&amp;author=J-S%20Hwang&amp;volume=25&amp;issue=6&amp;publication_year=2024&amp;pages=3095&amp;pmid=38542076&amp;doi=10.3390/ijms25063095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref040">
<span class="label">40.</span><cite>Fiorillo AA, Tully CB, Damsker JM, Nagaraju K, Hoffman EP, Heier CR. Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone. Physiol Genomics. 2018;50(9):735–45. doi: 10.1152/physiolgenomics.00134.2017

</cite> [<a href="https://doi.org/10.1152/physiolgenomics.00134.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6172612/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29883261/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiol%20Genomics&amp;title=Muscle%20miRNAome%20shows%20suppression%20of%20chronic%20inflammatory%20miRNAs%20with%20both%20prednisone%20and%20vamorolone&amp;author=AA%20Fiorillo&amp;author=CB%20Tully&amp;author=JM%20Damsker&amp;author=K%20Nagaraju&amp;author=EP%20Hoffman&amp;volume=50&amp;issue=9&amp;publication_year=2018&amp;pages=735-45&amp;pmid=29883261&amp;doi=10.1152/physiolgenomics.00134.2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref041">
<span class="label">41.</span><cite>Saghazadeh A, Rezaei N. MicroRNA expression profiles of peripheral blood and mononuclear cells in myasthenia gravis: A systematic review. Int Immunopharmacol. 2022;112:109205. doi: 10.1016/j.intimp.2022.109205

</cite> [<a href="https://doi.org/10.1016/j.intimp.2022.109205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36087508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Immunopharmacol&amp;title=MicroRNA%20expression%20profiles%20of%20peripheral%20blood%20and%20mononuclear%20cells%20in%20myasthenia%20gravis:%20A%20systematic%20review&amp;author=A%20Saghazadeh&amp;author=N%20Rezaei&amp;volume=112&amp;publication_year=2022&amp;pages=109205&amp;pmid=36087508&amp;doi=10.1016/j.intimp.2022.109205&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref042">
<span class="label">42.</span><cite>Yentrapalli R, Merl-Pham J, Azimzadeh O, Mutschelknaus L, Peters C, Hauck SM, et al. Quantitative changes in the protein and miRNA cargo of plasma exosome-like vesicles after exposure to ionizing radiation. Int J Radiat Biol. 2017;93(6):569–80. doi: 10.1080/09553002.2017.1294772

</cite> [<a href="https://doi.org/10.1080/09553002.2017.1294772" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28264626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Biol&amp;title=Quantitative%20changes%20in%20the%20protein%20and%20miRNA%20cargo%20of%20plasma%20exosome-like%20vesicles%20after%20exposure%20to%20ionizing%20radiation&amp;author=R%20Yentrapalli&amp;author=J%20Merl-Pham&amp;author=O%20Azimzadeh&amp;author=L%20Mutschelknaus&amp;author=C%20Peters&amp;volume=93&amp;issue=6&amp;publication_year=2017&amp;pages=569-80&amp;pmid=28264626&amp;doi=10.1080/09553002.2017.1294772&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref043">
<span class="label">43.</span><cite>Pan C, Shao S, Gu Y, Ni Q. Radiation prevents tumor progression by inhibiting the miR‑93‑5p/EphA4/NF‑κB pathway in triple‑negative breast cancer. Oncol Rep. 2023;49(4):78. doi: 10.3892/or.2023.8515

</cite> [<a href="https://doi.org/10.3892/or.2023.8515" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10018453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36866759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Rep&amp;title=Radiation%20prevents%20tumor%20progression%20by%20inhibiting%20the%20miR%E2%80%9193%E2%80%915p/EphA4/NF%E2%80%91%CE%BAB%20pathway%20in%20triple%E2%80%91negative%20breast%20cancer&amp;author=C%20Pan&amp;author=S%20Shao&amp;author=Y%20Gu&amp;author=Q%20Ni&amp;volume=49&amp;issue=4&amp;publication_year=2023&amp;pages=78&amp;pmid=36866759&amp;doi=10.3892/or.2023.8515&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref044">
<span class="label">44.</span><cite>Zhang N, Zhong Z, Wang Y, Yang L, Wu F, Peng C, et al. Competing endogenous network analysis identifies lncRNA Meg3 activates inflammatory damage in UVB induced murine skin lesion by sponging miR-93-5p/epiregulin axis. Aging (Albany NY). 2019;11(22):10664–83. doi: 10.18632/aging.102483

</cite> [<a href="https://doi.org/10.18632/aging.102483" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6914409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31761787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aging%20(Albany%20NY)&amp;title=Competing%20endogenous%20network%20analysis%20identifies%20lncRNA%20Meg3%20activates%20inflammatory%20damage%20in%20UVB%20induced%20murine%20skin%20lesion%20by%20sponging%20miR-93-5p/epiregulin%20axis&amp;author=N%20Zhang&amp;author=Z%20Zhong&amp;author=Y%20Wang&amp;author=L%20Yang&amp;author=F%20Wu&amp;volume=11&amp;issue=22&amp;publication_year=2019&amp;pages=10664-83&amp;pmid=31761787&amp;doi=10.18632/aging.102483&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref045">
<span class="label">45.</span><cite>Ryan JL. Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol. 2012;132(3 Pt 2):985–93. doi: 10.1038/jid.2011.411

</cite> [<a href="https://doi.org/10.1038/jid.2011.411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3779131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22217743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Invest%20Dermatol&amp;title=Ionizing%20radiation:%20the%20good,%20the%20bad,%20and%20the%20ugly&amp;author=JL%20Ryan&amp;volume=132&amp;publication_year=2012&amp;pages=985-93&amp;pmid=22217743&amp;doi=10.1038/jid.2011.411&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref046">
<span class="label">46.</span><cite>Chen C, Wang J, Pan D, Wang X, Xu Y, Yan J, et al. Applications of multi-omics analysis in human diseases. MedComm (2020). 2023;4(4):e315. doi: 10.1002/mco2.315

</cite> [<a href="https://doi.org/10.1002/mco2.315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10390758/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37533767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=MedComm%20(2020)&amp;title=Applications%20of%20multi-omics%20analysis%20in%20human%20diseases&amp;author=C%20Chen&amp;author=J%20Wang&amp;author=D%20Pan&amp;author=X%20Wang&amp;author=Y%20Xu&amp;volume=4&amp;issue=4&amp;publication_year=2023&amp;pmid=37533767&amp;doi=10.1002/mco2.315&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref047">
<span class="label">47.</span><cite>Acharya SS, Fendler W, Watson J, Hamilton A, Pan Y, Gaudiano E. Serum microRNAs are early indicators of survival after radiation-induced hematopoietic injury. Sci Transl Med. 2015;7(287):287ra69.</cite> [<a href="https://doi.org/10.1126/scitranslmed.aaa6593" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4686271/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25972001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Transl%20Med&amp;title=Serum%20microRNAs%20are%20early%20indicators%20of%20survival%20after%20radiation-induced%20hematopoietic%20injury&amp;author=SS%20Acharya&amp;author=W%20Fendler&amp;author=J%20Watson&amp;author=A%20Hamilton&amp;author=Y%20Pan&amp;volume=7&amp;issue=287&amp;publication_year=2015&amp;pmid=25972001&amp;doi=10.1126/scitranslmed.aaa6593&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref048">
<span class="label">48.</span><cite>Cui W, Ma J, Wang Y, Biswal S. Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry. PLoS One. 2011;6(8):e22988. doi: 10.1371/journal.pone.0022988

</cite> [<a href="https://doi.org/10.1371/journal.pone.0022988" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3157373/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21857976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Plasma%20miRNA%20as%20biomarkers%20for%20assessment%20of%20total-body%20radiation%20exposure%20dosimetry&amp;author=W%20Cui&amp;author=J%20Ma&amp;author=Y%20Wang&amp;author=S%20Biswal&amp;volume=6&amp;issue=8&amp;publication_year=2011&amp;pmid=21857976&amp;doi=10.1371/journal.pone.0022988&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref049">
<span class="label">49.</span><cite>Jacob NK, Cooley JV, Yee TN, Jacob J, Alder H, Wickramasinghe P, et al. Identification of sensitive serum microRNA biomarkers for radiation biodosimetry. PLoS One. 2013;8(2):e57603. doi: 10.1371/journal.pone.0057603

</cite> [<a href="https://doi.org/10.1371/journal.pone.0057603" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3581493/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23451251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Identification%20of%20sensitive%20serum%20microRNA%20biomarkers%20for%20radiation%20biodosimetry&amp;author=NK%20Jacob&amp;author=JV%20Cooley&amp;author=TN%20Yee&amp;author=J%20Jacob&amp;author=H%20Alder&amp;volume=8&amp;issue=2&amp;publication_year=2013&amp;pmid=23451251&amp;doi=10.1371/journal.pone.0057603&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref050">
<span class="label">50.</span><cite>Mueller A-K, Lindner K, Hummel R, Haier J, Watson DI, Hussey DJ. MicroRNAs and Their Impact on Radiotherapy for Cancer. Radiat Res. 2016;185(6):668–77. doi: 10.1667/RR14370.1

</cite> [<a href="https://doi.org/10.1667/RR14370.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27223830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiat%20Res&amp;title=MicroRNAs%20and%20Their%20Impact%20on%20Radiotherapy%20for%20Cancer&amp;author=A-K%20Mueller&amp;author=K%20Lindner&amp;author=R%20Hummel&amp;author=J%20Haier&amp;author=DI%20Watson&amp;volume=185&amp;issue=6&amp;publication_year=2016&amp;pages=668-77&amp;pmid=27223830&amp;doi=10.1667/RR14370.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref051">
<span class="label">51.</span><cite>Pichler M, Calin GA. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer. 2015;113(4):569–73. doi: 10.1038/bjc.2015.253

</cite> [<a href="https://doi.org/10.1038/bjc.2015.253" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4647691/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26158421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Cancer&amp;title=MicroRNAs%20in%20cancer:%20from%20developmental%20genes%20in%20worms%20to%20their%20clinical%20application%20in%20patients&amp;author=M%20Pichler&amp;author=GA%20Calin&amp;volume=113&amp;issue=4&amp;publication_year=2015&amp;pages=569-73&amp;pmid=26158421&amp;doi=10.1038/bjc.2015.253&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0329737.ref052">
<span class="label">52.</span><cite>Loinard C, Benadjaoud MA, Lhomme B, Flamant S, Baijer J, Tamarat R. Inflammatory cells dynamics control neovascularization and tissue healing after localized radiation induced injury in mice. Commun Biol. 2023;6(1):1–12.
</cite> [<a href="https://doi.org/10.1038/s42003-023-04939-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10227012/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37248293/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Commun%20Biol&amp;title=Inflammatory%20cells%20dynamics%20control%20neovascularization%20and%20tissue%20healing%20after%20localized%20radiation%20induced%20injury%20in%20mice&amp;author=C%20Loinard&amp;author=MA%20Benadjaoud&amp;author=B%20Lhomme&amp;author=S%20Flamant&amp;author=J%20Baijer&amp;volume=6&amp;issue=1&amp;publication_year=2023&amp;pages=1-12&amp;pmid=37248293&amp;doi=10.1038/s42003-023-04939-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="pone.0329737.r001"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0329737.r001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329737.r001</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 0</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20DX%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Daniel X Zhang</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Daniel X Zhang</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20DX%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniel X Zhang</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Daniel X Zhang</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.c" class="d-panel p" style="display: none">
<div>© 2025 Daniel X Zhang</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>3 Jun 2025</em>
</p>
<p>Dear Dr. FLAMANT,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Please submit your revised manuscript by Jul 18 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <span>plosone@plos.org</span> . When you're ready to submit your revision, log on to <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.editorialmanager.com/pone/</a> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<ul class="list" style="list-style-type:disc">
<li><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></li>
<li><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></li>
<li><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></li>
</ul>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <a href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</a> . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <a href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</a> .</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Dr. Daniel X Zhang</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal requirements:</p>
<p>When submitting your revision, we need you to address these additional requirements.</p>
<p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
<p><a href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</a> and</p>
<p>
<a href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</a>
</p>
<p>2. Thank you for your submission to PLOS ONE. We note that your study design may include death of a regulated animal as a likely outcome or planned experimental endpoint. At this time, we request that you please report additional details in your Methods section regarding animal care and use for the survival study, as per our editorial guidelines (<a href="http://journals.plos.org/plosone/s/submission-guidelines#loc-humane-endpoints).%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://journals.plos.org/plosone/s/submission-guidelines#loc-humane-endpoints).     </a></p>
<p>For easy reference, we have attached a checklist that may be relevant for your submission. Please complete all items on the checklist at the following link:   <a href="http://journals.plos.org/plosone/s/file?id=bb1d/plos-one-humane-endpoints-checklist.docx%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0%C2%A0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://journals.plos.org/plosone/s/file?id=bb1d/plos-one-humane-endpoints-checklist.docx        </a></p>
<p>Please upload the completed checklist as file type “Other” when resubmitting your manuscript. This document is for internal journal use only and will not be published if your article is accepted. We very much appreciate your attention to these requests and support of improved reporting standards in PLOS ONE submissions.</p>
<p>3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>1. Is the manuscript technically sound, and do the data support the conclusions?</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>2. Has the statistical analysis been performed appropriately and rigorously? --&gt;?&gt;</p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>3. Have the authors made all data underlying the findings in their manuscript fully available??&gt;</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a></p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>4. Is the manuscript presented in an intelligible fashion and written in standard English??&gt;</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>Reviewer #1: This is an important study that should be published so that others can build on it. Experiments were done thoroughly. Data analysis with miRNA is challenging and the robustness of the authors conclusions will only be determined over time as others build on it. The results are interesting but not convincing. To support that, the following needs to be clarified.</p>
<p>1. Which samples were rejected (hemolysis, etc.) based on their various quality criteria should be noted. For instance, in the D1 broad spectrum, only 40 of the 60 animals are reported.</p>
<p>2. The qPCR controls should be reported.</p>
<p>3. qPCR standard curves for the kits used should be reported</p>
<p>4. Were there any normalization steps taken? This should be clearly stated and described.</p>
<p>5. In the prognostic model, what were the D14 scores? It should also be in the supplemental data.</p>
<p>Reviewer #2: Title: Presymptomatic microRNA-based biomarker signatures for the prognosis of localized radiation injury in mice</p>
<p>Author(s): Lucie Ancel, Jules Gueguen, Guillaume Thoer, Jules Marçais, Aïda Chemloul, Bernard Le Guen, Marc Benderitter, Radia Tamarat, Maâmar Souidi, Mohamed Amine Benadjaoud, Stéphane Flamant</p>
<p>Reviewer´s comments:</p>
<p>The presented article by authors Ancel et al. aimed to identify plasma miRNA signatures that might be used for the prognosis of localized radiation injury severity before symptoms appear. The authors already have experience in this field, referring to their previous publications (<a href="https://doi.org/10.1038/s41598-024-52258-2;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1038/s41598-024-52258-2;</a>
<a href="https://doi.org/10.1038/s41598-025-85717-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1038/s41598-025-85717-5</a>) that are properly cited in this manuscript. To obtain study results, the authors used suitable methodologies as well as statistical analyses. I appreciate that the identified candidate miRNAs were refined using two independent mouse cohorts.</p>
<p>Early diagnosis of localized radiation injury as well as setting up the appropriate treatment are hampered due to its presymptomatic phase. Therefore, research in the area of potential biomarkers for early prediction of radiation injury severity is very welcomed. New knowledge in this field could help to improve patient management and treatment outcomes in radiological emergency situations. This is a well-written manuscript containing promising results that point to the possible role of selected miRNAs in predicting the severity of localized radiation injury. All presented data are appropriately discussed and graphically illustrated. However, the quality of all figures is very bad and needs to be improved, some figures were not even readable.</p>
<p>I have the following recommendations to improve the manuscript:</p>
<p>1. As I already mentioned, the quality of all figures needs to be improved.</p>
<p>2. Line 91: The authors did not explain the abbreviation NHPs, this should be fixed.</p>
<p>Based on previous comments, I recommend this article to be accepted for publication after minor revision in this journal.</p>
<p>**********</p>
<p><a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a></p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: No</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <a href="https://pacev2.apexcovantage.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pacev2.apexcovantage.com/</a> . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <span>figures@plos.org</span></p></section></article><article class="sub-article" id="pone.0329737.r002"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. 2025 Aug 8;20(8):e0329737. doi: <a href="https://doi.org/10.1371/journal.pone.0329737.r002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329737.r002</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Author response to Decision Letter 1</h1></hgroup><ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="anp_a.d" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.d" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="anp_a.d" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub2" class="history"><p>Collection date 2025.</p></section></div></div>
<div id="clp_a.d" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>30 Jun 2025</em>
</p>
<p>Point-by-point response to the reviewers’ comments</p>
<p>Dear Editor and reviewers,</p>
<p>We are pleased to produce below a point-by-point response to reviewer’s comments. We thank the reviewers for their thorough analysis of our work and their comments and remarks, which led to modifications of the manuscript that should allow a better understanding of our study.</p>
<p>In particular we clarified the discrepancy between the total number of animals involved in the study and samples used for multivariate analyses. We also addressed the comments regarding the analysis of qPCR data by adding more details on the adaptive normalization procedure and providing the supporting S4 Table with quality check data.</p>
<p>In addition, we corrected the column headings with erroneous labels in Table 1 and provide supporting D14 injury scores in the supplementary S5 Table.</p>
<p>The modifications of the text are highlighted in yellow in this revised version.</p>
<p>Reviewer #1:</p>
<p>This is an important study that should be published so that others can build on it. Experiments were done thoroughly. Data analysis with miRNA is challenging and the robustness of the authors conclusions will only be determined over time as others build on it. The results are interesting but not convincing. To support that, the following needs to be clarified.</p>
<p>1. Which samples were rejected (hemolysis, etc.) based on their various quality criteria should be noted. For instance, in the D1 broad spectrum, only 40 of the 60 animals are reported.</p>
<p>A total of 60 animals (15 per group) were included in each study. This number was chosen based on the team's prior experience, with the aim of obtaining plasma samples of up to 10 animals per group for molecular analyses.</p>
<p>It is well established from previous studies that some animals or samples may be excluded from the study due to various factors. In particular, any animal showing signs of skin injury resulting from aggressive behavior within the cages was excluded from all analyses. This was done to avoid introducing bias when evaluating skin-muscle injury biomarkers. Additional common reasons for exclusion included inadequate blood sample quality, such as insufficient volume, hemolysis, or suspected RNA degradation. Moreover, parts of plasma volume were allocated to metabolomics studies (paper in preparation), similar to our previous study at D14 (Ancel 2025, ref 27).</p>
<p>However, these sample quality issues did not compromise the reliability of the clinical assessments and functional monitoring conducted during the animals’ lifetime, including injury score, cutaneous blood perfusion, transepidermal water loss, and complete blood counts (CBC), the latter of which was performed using an independent retro-orbital blood sampling method.</p>
<p>As a result, the number of animals reported in clinical and functional follow-up may differ from those included in molecular analyses. Only animals with high-quality data across all molecular, clinical and functional endpoints were retained for multivariate analyses. In any case, exposure to RI or dose group were not specifically associated with sample exclusion decision.</p>
<p>Given this framework, the target number for molecular analyses was set to 6-10 animals per group, even if a higher number of animals yielded blood samples of sufficient quality. Any surplus samples were stored for potential future analyses. Nevertheless, we chose to present all available data related to clinical and functional assessments (Fig.1 &amp; 2) in order to highlight the robustness and consistency of our preclinical LRI model.</p>
<p>2. The qPCR controls should be reported.</p>
<p>As requested, qPCR Ct values for spike-in and controls for the samples used in multivariate analysis are now provided as supplementary file S4 Table.</p>
<p>3. qPCR standard curves for the kits used should be reported.</p>
<p>In this study, we used the complete miRCURY solution (Qiagen) to perform the RT-qPCR experiments. RT reaction was performed using the miRCURY LNA RT kit. The qPCR reactions were conducted using the 2x miRCURY LNA SYBR Green PCR Master Mix, first on the miRCURY LNA miRNA Mouse &amp; Rat miRNome panels I+II (for broad spectrum analyses), then on miRCURY LNA miRNA custom panels (for targeted analyses) designed according to Qiagen GeneGlobe recommendations.</p>
<p>All these PCR panels used proprietary LNA-enhanced primers for miRNA amplification that were specifically designed in order to amplify miRNAs under the same experimental conditions and with high discriminatory power between closely related miRNA sequences. Similar to our previously published study (Ancel 2024, ref 26), we considered that these LNA miRNA assays were fully validated and optimized and that the manufacturer provided satisfactory information regarding assay parameters including detection range and standard curve (as shown on their website at <a href="https://www.qiagen.com/us/products/discovery-and-translational-research/pcr-qpcr-dpcr/qpcr-assays-and-instruments/mirna-qpcr-assay-and-panels/mircury-lna-mirna-pcr-assays" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.qiagen.com/us/products/discovery-and-translational-research/pcr-qpcr-dpcr/qpcr-assays-and-instruments/mirna-qpcr-assay-and-panels/mircury-lna-mirna-pcr-assays</a>). In addition, we used the reagents recommended by the manufacturer (i.e. 2x miRCURY LNA SYBR Green PCR Master Mix) to optimize amplification performances. We used the -ΔCt values obtained following data normalization with the MiRAnorm package (see answer to comment #4 below) to perform the multivariate analyses described in this study.</p>
<p>4. Were there any normalization steps taken? This should be clearly stated and described.</p>
<p>As we mentioned in the M&amp;M section of the manuscript, the ΔCt values were obtained through an adaptive normalization combining clustering and selection of the most stable cluster. As suggested by the reviewer, we improved the revised manuscript by describing the approach in more details with additional technical information (p10, line 214):</p>
<p>“Delta-Ct values were calculated using adaptive normalization from “MiRAnorm” package in R Software, as described [29]. Briefly, Delta-Ct values were obtained by subtracting the assay’s Ct values by the mean of an adaptive set of normalizing miRNAs derived from the data through a hierarchical clustering approach based on Euclidean distance and Ward agglomeration method. This set of normalizing miRNAs was obtained by cutting the dendrogram tree from bottom up according to a pre-specified number of three normalizing miRNAs and the most stable cluster minimizing the sum of all distances from its centroid was retained.”</p>
<p>5. In the prognostic model, what were the D14 scores? It should also be in the supplemental data.</p>
<p>We apologize for the mislabeling of the column headings corresponding to miRNA name and stability score in Table 1. We modified the Table 1 accordingly, with modifications highlighted in yellow. Moreover, as suggested by the reviewer, we now report the D14 injury scores in the supplementary document S5 Table. These values correspond to animals from our previous study (Ancel 2024, ref 26).</p>
<p>Reviewer #2:</p>
<p>The presented article by authors Ancel et al. aimed to identify plasma miRNA signatures that might be used for the prognosis of localized radiation injury severity before symptoms appear. The authors already have experience in this field, referring to their previous publications (<a href="https://doi.org/10.1038/s41598-024-52258-2;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1038/s41598-024-52258-2;</a>
<a href="https://doi.org/10.1038/s41598-025-85717-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1038/s41598-025-85717-5</a>) that are properly cited in this manuscript. To obtain study results, the authors used suitable methodologies as well as statistical analyses. I appreciate that the identified candidate miRNAs were refined using two independent mouse cohorts.</p>
<p>Early diagnosis of localized radiation injury as well as setting up the appropriate treatment are hampered due to its presymptomatic phase. Therefore, research in the area of potential biomarkers for early prediction of radiation injury severity is very welcomed. New knowledge in this field could help to improve patient management and treatment outcomes in radiological emergency situations. This is a well-written manuscript containing promising results that point to the possible role of selected miRNAs in predicting the severity of localized radiation injury. All presented data are appropriately discussed and graphically illustrated. However, the quality of all figures is very bad and needs to be improved, some figures were not even readable.</p>
<p>I have the following recommendations to improve the manuscript:</p>
<p>1. As I already mentioned, the quality of all figures needs to be improved.</p>
<p>Thank you for your favorable comment. As a matter of fact, we were also surprised at first when we downloaded the compiled pdf document automatically prepared by the PLOS One submission system and we saw the poor quality of the figures. In fact, at the top right of each figure page in the pdf document, there is a link to download the original .tif figure, so you can read the details and the writing in high quality.</p>
<p>2. Line 91: The authors did not explain the abbreviation NHPs, this should be fixed.</p>
<p>The modification was made.</p>
<section class="sm xbox font-sm" id="pone.0329737.s007"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Answers to reviewers_250630.pdf</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s007.pdf" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s007.pdf</a><sup> (103.6KB, pdf) </sup>
</div></div></section></section></article><article class="sub-article" id="pone.0329737.r003"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0329737.r003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329737.r003</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Decision Letter 1</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20DX%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Daniel X Zhang</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Daniel X Zhang</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20DX%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniel X Zhang</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.e" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.e" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.e" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Daniel X Zhang</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.e" class="d-panel p" style="display: none">
<div>© 2025 Daniel X Zhang</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>
<em>22 Jul 2025</em>
</p>
<p>Presymptomatic microRNA-based biomarker signatures for the prognosis of localized radiation injury in mice</p>
<p>PONE-D-25-26068R1</p>
<p>Dear Dr. FLAMANT,</p>
<p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
<p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
<p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <a href="https://www.editorialmanager.com/pone/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Editorial Manager®</a>  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>Kind regards,</p>
<p>Daniel X Zhang</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Additional Editor Comments (optional):</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p>
<strong>Comments to the Author</strong>
</p>
<p>Reviewer #1: All comments have been addressed</p>
<p>Reviewer #2: All comments have been addressed</p>
<p>**********</p>
<p>2. Is the manuscript technically sound, and do the data support the conclusions??&gt;</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>3. Has the statistical analysis been performed appropriately and rigorously? --&gt;?&gt;</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>4. Have the authors made all data underlying the findings in their manuscript fully available??&gt;</p>
<p>The <a href="http://www.plosone.org/static/policies.action#sharing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PLOS Data policy</a></p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>5. Is the manuscript presented in an intelligible fashion and written in standard English??&gt;</p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>**********</p>
<p>Reviewer #1: (No Response)</p>
<p>Reviewer #2: The Authors adressed all my comments I had in my previous review report. I have no further requirements. Based on this statement I recommend accepting the manuscript it in its current form.</p>
<p>**********</p>
<p><a href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">what does this mean?</a> ). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><strong>Do you want your identity to be public for this peer review?</strong> For information about this choice, including consent withdrawal, please see our <a href="https://www.plos.org/privacy-policy" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Privacy Policy</a></p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: No</p>
<p>**********</p></section></article><article class="sub-article" id="pone.0329737.r004"><section class="pmc-layout__citation font-secondary font-xs"><div>PLoS One. doi: <a href="https://doi.org/10.1371/journal.pone.0329737.r004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0329737.r004</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Acceptance letter</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20DX%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Daniel X Zhang</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Daniel X Zhang</span></h3>
<div>Academic Editor</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20DX%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniel X Zhang</span></a>
</div>
</div>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.f" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="clp_a.f" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.f" class="d-panel p" style="display: none">
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Daniel X Zhang</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="clp_a.f" class="d-panel p" style="display: none">
<div>© 2025 Daniel X Zhang</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>PONE-D-25-26068R1</p>
<p>PLOS ONE</p>
<p>Dear Dr. FLAMANT,</p>
<p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p>
<p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p>
<p>* All references, tables, and figures are properly cited</p>
<p>* All relevant supporting information is included in the manuscript submission,</p>
<p>* There are no issues that prevent the paper from being properly typeset</p>
<p>You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.</p>
<p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p>
<p>You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at <a href="https://explore.plos.org/phishing" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://explore.plos.org/phishing</a>.</p>
<p>If we can help with anything else, please email us at customercare@plos.org.</p>
<p>Thank you for submitting your work to PLOS ONE and supporting open access.</p>
<p>Kind regards,</p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Dr. Daniel X Zhang</p>
<p>Academic Editor</p>
<p>PLOS ONE</p></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 Fig. CBC at D1 post-irradiation.</span><p>Each animal is represented (n = 13–15/group). Kruskal-Wallis analysis, * <em>P</em> &lt; 0.05; *** <em>P</em> &lt; 0.001; **** <em>P</em> &lt; 0.0001. RBC, red blood cells; Hb, hemoglobin; Ht, hematocrit; PLT, platelet; WBC, white blood cells; NEU, neutrophils; LYM, lymphocytes; MCHC, Mean corpuscular hemoglobin concentration; MCH, mean corpuscular hemoglobin; MONO, monocytes.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s001.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s001.tif</a><sup> (437.7KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S2 Fig. CBC at D7 post-irradiation.</span><p>Each animal is represented (n = 12–15/group). Kruskal-Wallis analysis.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s002.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s002.tif</a><sup> (464.2KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>S3 Table. Raw data for each cohort of the study.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s003.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s003.xlsx</a><sup> (299.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>S4 Table. Raw data of QC miRNAs and controls for each cohort.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s004.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s004.xlsx</a><sup> (19.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p">
<span>S5 Table. Injury scores and laser Doppler skin perfusion ratios (IRR/NIR) at day-14 (from ref26).</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s005.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s005.xlsx</a><sup> (12.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p">
<span>Attachment</span><p>Submitted filename: <em>Answers to reviewers_250630.pdf</em></p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333984/bin/pone.0329737.s007.pdf" data-ga-action="click_feat_suppl" class="usa-link">pone.0329737.s007.pdf</a><sup> (103.6KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>All relevant data are within the paper and its <a href="#sec024" class="usa-link">Supporting Information</a> files.</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0329737"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0329737.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12333984/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12333984/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12333984%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333984/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12333984/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12333984/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40779592/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12333984/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40779592/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12333984/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12333984/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="fjB2wuDPOt3ymxXgPJ1JYyQOhK5hROKMd29TuJKUB2V2UW7PGa2Z3fHFFBRZscdv">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
